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Abstract 
 Physiologically relevant scaffold-based tissue engineered structures have been limited in scope 
and viability by the diffusion limits of oxygen and other nutrients and functions provided by native 
vasculature in vivo. This has prevented the maintenance of healthy cell populations in scaffolds that are 
more than 200µm thick. Combining concepts from microfluidics with biomaterials engineering, this 
project set out to engineer a perfusable fibrin-based vascular network capable of physiologically 
relevant flow properties as well as diffusion that supports viable cell populations. To create this system, 
a small artery sized (1.5 mm wide) gelatin sacrificial structure was embedded inside of a block of robust 
fibrin gel (4.26% w/v fibrin) then melted and rinsed out to create a perfusable vascular network. 
Characterization consisted of morphometric and histological analyses for channel sizes compared to the 
sacrificial structures, particle tracking to observe flow properties, and fluorescent dextran diffusion to 
measure diffusivity into the fibrin scaffold. We found that channels derived from sacrificial structures 
maintain their size and shape inside of the gel. Flow properties of the fluid through the channels were 
found to be both laminar and within expected physiological rates compared to native vessels of similar 
sizes. Cells on the surface of the fibrin vascular device expressed fluorescent markers that were 
delivered through the vascular network and perfused through the fibrin scaffold.  These findings suggest 
that a fibrin based vascular system may provide a platform creating a functional vascular layer and for 
developing tissue engineered systems of increased size and complexity. 
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Chapter 1: Introduction 
 With very few exceptions, cells are not capable of survival more than 200µm away from a 
source of oxygen, a source of nutrients, and metabolic waste removal [1]. In vivo, this source takes the 
form of the vascular network, which is made of a complex branching system of veins, arteries, arterioles, 
and capillaries which contact every area of tissue and organ [2]. Should the vasculature become 
damaged, diseased, or removed, as in the case of myocardial infarction or volumetric muscle loss, the 
lack of blood flow to the area causes tissue death. This dead tissue cannot be regenerated. In its place 
will be avascular scar tissue, which does not function the same way as the ischemic tissue [3], [4].  
 The need for vascularization has also been a major limitation in the development of full 
thickness tissue engineered constructs and grafts [1]. Vascular engineering has become a large and 
varied field aimed at addressing this concern. A wide variety of both natural and synthetic materials are 
used to fabricate vasculature in vitro. Synthetic materials have been very successful in producing 
geometrically complex systems. However, they tend to see only limited bioactivity [1], [5]. Natural 
materials, such as collagen, ECM, and fibrin, are more capable of supporting healthy cell populations and 
provide better remodeling, but suffer in their ability to make complex channel geometries, mechanical 
properties, and have been found to leak [1], [5, 6]. Both methods have proven viable for applications, 
like drug testing and in vitro modeling, but overall, there is neither a perfect method of nor a perfect 
material for vascular engineering [7]. 
 The goal of this project was to develop a novel method for the fabrication of a single layered 
fibrin based vascular network that was able to reliably produce channels, had flow properties that 
were physiologically relevant, and had diffusion rates that were capable of sustaining a viable cell 
population on the surface. For the purpose of this study, a larger channel size was targeted, one that 
mimicked small arteries rather than microvasculature. That is because this thesis was a large-scale proof 
of concept exploring the feasibility and functionality of such a system.  
15 
 
 The objectives of these studies were centered around the development and characterization of 
a perfusable fibrin based vascular network. Once the network fabrication was successful, several 
characteristics were measured to establish consistency and compare to physiological values. These were 
as follows: 
• A morphometric and histological analysis of sacrificial structure and channel sizes to establish 
consistency and reliability of channel fabrication methods 
• Flow analysis focused on the ability of the system to maintain expected flow rates, laminar flow, 
and wall shear stress values similar to physiological values to ensure the system was 
physiologically relevant 
• Diffusivity calculations to measure and understand the ability of the system to diffuse micro- 
and macromolecules outside of the channels 
• Evaluate cell viability on the surface of the fibrin vascular device to establish the ability of the 
system to maintain cell populations 
A variety of techniques were used to address each of the goals listed above. The sacrificial 
structure technique was selected to fabricate the channels within the fibrin vascular devices due to its 
versatility and simplicity, as well as the ease at which a single layered system could be created to 
address frequent problems with hydrogel based vascular engineering, like backflow and leakage [6]. 
Histology and microscope imaging were used for the morphometric analysis of channels and sacrificial 
structures. The findings showed no statistical difference between them, and that they achieved the goal 
of mimicking small arterial dimensions [8, 9]. The flow analysis was performed by perfusing polystyrene 
microbeads through the fibrin vascular device. The average particle speed obtained from this study 
allowed the calculation of a variety of flow properties, including volumetric flow rate, which closely 
matched expected values, Reynolds number, which showed our flow to be laminar, as it is in vivo, and 
wall shear stress which was below the physiological maximum within our system [10]. Perfusion of two 
16 
 
different molecular weights of fluorescent dextran were used to measure the diffusive properties of the 
gel. Finally, a perfusion of calcein AM dye was used to observe cellular uptake on a cover slip on the 
surface of a fibrin vascular device, to prove that fibrin vascular devices can supply cells with nutrients. 
Overall, the morphological, diffusive, and flow properties of a monolayered fibrin vascular 
device showed strong correlation to physiological values. Channel areas were an average of 1.10 mm2 
and showed no significant difference between the size of the channels and the size of the sacrificial 
structures. An average flow rate of 0.204 mm3/s, a Reynolds number of 1.15×10-3 and a wall shear stress 
of 0.385 N/m2 all fall within physiological values. These experiments also successfully addressed several 
problems common with hydrogel based fluidic systems. These promising results provide a strong 
argument for the continuation of development of this system, with the end goal of creating a functional 
microvascular network for an array of uses, including vascularization of full thickness tissue engineered 
constructs, and as a platform for in vitro drug testing assays. 
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Chapter 2: Background 
 This project centers around the fabrication and characterization of a novel engineered 
vasculature for the purposes of developing full thickness engineered tissues, patches, and even as an in 
vitro platform for drug testing. The development of this device requires a background understanding of 
the purpose of vasculature, existing engineered tissue, and what is being researched in the world of 
vascular engineering and microfluidics for the purpose of vascular engineering. Finally, this section will 
discuss the materials chosen for this project, and the logic behind those choices in order to develop 
vasculature that is biocompatible and functional. 
2.1: Vasculature Function 
 The vascular network is the system of arteries, veins, arterioles, and capillaries that 
carry blood from the heart to nearly 
every tissue and organ throughout 
the body [2]. Blood vessels in this 
network, with diameters ranging 
from arteries up to 6mm to 
capillaries as small as 5µm, are 
made of smooth muscle with a 
single layer of endothelial cells 
lining the inside [8, 9]. As outlined 
in Figure 1 to the right, vasculature 
provides nearby cells with oxygen and other nutrients, and serves as the mechanism for the removal of 
metabolic waste. Due to the diffusion limit and consumption of oxygen, cells are unable to survive more 
than 200µm from the closest blood vessel, meaning that capillaries are widespread and numerous [1, 
Figure 1: Schematic of vascular function. Adapted from Novesel et al. 
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11]. It also means that when vasculature is damaged or otherwise dysfunctional, there are major 
repercussions in the health of the individual, including myocardial infarction in the event of cardiac 
vasculature becoming compromised and volumetric muscle loss within skeletal muscle tissue. 
2.1.1: Myocardial Infarction 
The treatment of patients with damage to their organs or tissues accounts for over half of all 
medical costs in the United States of America [7]. Between 2011 and 2014, over 7.9 million of the 
patients responsible for this cost, approximately 4.9 million of whom were men, suffered from a 
myocardial infarction, or heart attack [12]. In 2014, 114,000 of these cases resulted in death [12]. 
Myocardial infarction occurs due to a thrombic occlusion of a cardiac artery that lasts for longer than 20 
minutes [3], [13]. The resulting ischemia, or lack of blood flow, causes the death of myocardial tissue [3]. 
Unfortunately, the mammalian heart has limited regenerative properties, meaning that the 
ischemic area fills in with avascular collagenous scar tissue rather than functional cardiac muscle [3]. 
While this scar tissue is initially useful in providing mechanical support for the heart and preventing 
further damage to the heart wall, they also change the ventricle geometry and alter the mechanical 
properties of the heart, thus changing the way it beats [4]. This alteration of the cardiac tissue caused by 
this fibrosis eventually results in heart dilation, which can ultimately cause heart failure [4, 14]. In 
summary, the damage of vascular tissue in the heart is dangerous and frequently deadly due to the 
inability of cardiac muscle to remodel in the absence of nutrients and oxygen. 
2.1.2: Volumetric Muscle Loss 
 When an injury destroys more than 20% of a specific muscle, it is considered to be an area of 
volumetric muscle loss [15]. This means the tissue in the area is incapable of regenerating in the same 
way a smaller injury could. This is due to the destruction of the basement membrane, connective tissue, 
and vascular tissue in the area. Removal of these tissues means that the biochemical, structural, and 
mechanical cues that the body normally uses to regenerate are not present [15]. Vasculature is 
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especially difficult to regenerate, and, much like the heart after myocardial infarction, the lack of 
nutrients and waste removal leads to the area filling with avascular scar tissue [15]. The results of excess 
scar tissue in the injured area are also similar to occurrences in the heart. The muscle in the area is 
never able to regain its full strength and function, and as of now, there are no treatments available to 
restore full function in these injuries [15]. In extreme cases of volumetric muscle loss, full limb 
amputation becomes necessary due to the inability of the body to regenerate function [15]. This is 
another case where the lack of vascular tissue in an area causes severe and irreparable damage to the 
body and has a massive impact on health and quality of life. It is for these reasons that it is important to 
find a way to reliably produce engineered vasculature to replace damaged or diseased tissue, and why it 
has become a major focus of the tissue engineering community. 
2.2: Microvascular grafts 
 Vascular grafts are the current gold standard of treatment for damaged or diseased vasculature. 
The first vascular autograft was performed in 1949 [5]. This is a graft made with a patient’s own 
endothelial cells and fibroblasts, and, while not a perfect treatment, it has seen considerable success [7]. 
Depending on the needs of the patient, there are two types of vasculature that can be grafted: 
macrovasculature, such as veins and arteries, and microvasculature. Should there be a need for a 
macrovascular autograft, a patient’s own veins can be transplanted to the appropriate area of the body. 
In other cases where a microvascular graft is necessary, it is more common to use a pedicle flap. 
 Microvascular grafts work differently than their larger counterparts. Rather than harvesting a 
patient’s vein to replace a large portion of damaged tissue, microvasculature is replaced using 
something called a pedicle flap. These are autologous tissue lifted from a donor site and moved to the 
implant site. This is often done underneath the healthy tissue. It is performed in this manner because 
the donated flap is not disconnected from its blood supply until a new, properly functional blood supply 
has been formed at the site of implantation. Pedicle flaps have been used in and have seen significant 
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success across multiple applications, including the treatment of severe burns or trauma, breast 
reconstruction, and at sites of tumor resection [16], [17], [18]. Unfortunately, these pedicle flap grafts 
have several limitations. It is difficult to maintain these grafts in an angle and position that does not 
damage the blood supply to the flap. The vein can become compressed, and if not properly attached, 
the entire flap can shift [17]. There is also a large amount of donor site morbidity, and difficulties have 
arisen with the vascular inosculation of donor and implant site blood vessels [16]. 
 While autografts have seen great success in many cases, they are not an ideal choice for all 
situations or patients. They also apply exclusively to vascular damage; autografts have not been used in 
other engineered tissue. A pressing need remains for engineered vasculature, both for the purposes of 
full thickness tissue engineering, as well as in vitro models for drug testing and vascular disease 
modeling [1]. 
2.3: Vascular Engineering 
 As previously discussed, the creation of a vascular substitute is vital for the creation of full 
thickness engineered tissue, and it has 
thus been a major area of research [19, 
20]. The ultimate goal of tissue 
engineering is to create functional tissues 
in vitro and transplant them in vivo or to 
use them as in vitro models, an example 
schematic of which is in Figure 2 [1]. The 
most successful tissue engineered 
constructs have involved three major 
parts: cells, a scaffold for extracellular matrix (ECM), and signals to direct repair and regeneration [7]. 
Unfortunately, due to difficulties with the creation of vasculature, the current state of engineering 
Figure 2:Schematic of a full thickness vascularized patch. Credit to Alexander 
Hallet 
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technology focuses more on repair and regeneration of damaged tissue than replacement [5]. There are 
two major approaches to vascular engineering: acellular scaffold based methods, and cellular methods. 
Each of these methods have benefits and limitations. 
2.3.1: Acellular Vasculature Engineering Strategies 
Acellular scaffold guided vascular regeneration has been a major area of exploration for 
engineers in the tissue engineering field [5]. Acellular scaffolds encompass a very broad range of 
materials and techniques, including use of both synthetic and natural materials, and addressing 
vasculature of multiple sizes [5]. The few universal requirements include sufficient porosity to promote 
cell growth, and allowance for the exchange of nutrients and waste [5]. It is also ideal for scaffolds 
intended for grafting to have a burst pressure greater than 1700 mmHg and the ability to resist fatigue 
from cyclic loading for at least 30 days in vitro without dilation [5]. These values make the developed 
scaffold more likely to be useful in vivo. With these factors in mind, a variety of both synthetic and 
natural materials have been used to model vasculature. 
Synthetic materials for vascular grafts must be carefully considered across a range of criteria. 
Among these are the thromboresistance and mechanical compliance [5]. Additionally, it is preferable 
that the chosen material does not induce hyperplasia as a result of being implanted into the body [5]. 
These all must be considered in order to prevent total failure of the engineered graft, either due to 
mechanical strain, immune rejection, or thrombosis. Materials that have proven themselves viable 
according to these parameters include Dacron and Teflon [5]. 
These materials are ideal, not only for their response in the body, but also their versatility to be 
used in multiple fabrication techniques. They can be made in high volumes, and formed into extremely 
small and complex geometries, without sacrificing their desirable and easily manipulated mechanical 
properties [5]. Unfortunately, these synthetic materials do have a major drawback: their lack of 
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bioactivity [1], [5]. This means that while cells are capable of living on scaffolds made from these 
materials, they often do not do very much to promote cell growth and healing. 
  To promote a more active healing environment, it is common to use natural materials in place of 
synthetic materials in a scaffold. These materials have many benefits over their synthetic counterparts: 
the bioactivity previously mentioned, and being biocompatible in bulk tissue [1]. These materials often 
also have relevant geometries, such as pores, already in place [1]. Materials such as fibrin, collagen, and 
ECM have become popular due to their ability to mimic necessary properties of native tissue [7]. It is 
also common to utilize natural structures that have been decellularized with detergents, leaving only a 
scaffold. These scaffolds range in material from cellulose based spinach leaves to full ECM organs [21, 
22]. In all cases, however, these structures are fully perfusable and, while they suffer in mechanical 
properties, maintain a complex vascular structure able to be seeded with cells [21, 22]. Overall, these 
natural scaffolds provide far better remodeling than has been seen with synthetic scaffolds [5]. There 
are, however, limitations to using these natural materials. 
The most prominent problem with the use of natural material is the mismatch of mechanical 
properties between these natural scaffolds and native tissue. Specifically with collagen, a clear 
compliance mismatch was seen, and the addition of a material like Dacron has been shown to cause 
negative responses [5]. Despite the use of adding other natural fibers, like silk, and laminating layers of 
biomaterial together, mechanical properties of the natural material scaffolds remain inferior to 
synthetic materials. It is also difficult to standardize and reproduce natural scaffolds [1]. 
 The use of acellular scaffolds for vascular engineering is an active and powerful area of research 
with many varied materials, techniques, and limitations associated with it. Synthetic scaffolds provide 
excellent mechanical properties and are easily used to make reproducible small geometries, but are 
severely lacking in their biocompatibility and bioactivity, providing overall poor remodeling. Natural 
materials provide much better remodeling, both of vasculature and the surrounding tissue, but inferior 
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mechanical properties and difficulties reproducing proper geometries lead to difficulties in use. Despite 
this, scaffolds are highly promising and very important to the success of a vascular graft. 
2.3.2: Cellular Vascular Engineering Strategies  
 Cellular vascular engineering typically involves a scaffold seeded with cells and growth factors 
among other signals to induce the growth of the desired vascular tissue. Multiple cell types must be 
used to create a graft sufficiently similar to vascular tissue to be clinically and theoretically relevant. 
These cells include endothelial cells, fibroblasts, and smooth muscle cells [5]. Besides the proper type, it 
is vital that these cells are also nonimmunogenic, highly proliferative, and most importantly that they 
are able to function normally [5]. Among these cell types, endothelial cells might be the most 
imperative. Endothelial cells line the inner layer of all vasculature and help to provide 
thromboresistance, preventing pseudo-intimal hyperplasia [7]. This subsection discusses a few broad 
techniques used for the development of engineered cellular vascular grafts, their benefits, and their 
limitations. 
 Prevascularization in vitro is the process by which a scaffold is seeded with appropriate cells in a 
lab environment and carefully cultured to obtain the desired cell functionality before implantation [1]. 
This technique has been shown to greatly reduce the time necessary for vasculature to grow in vivo, as it 
eliminates the need for host endothelial cells to grow to the center of the tissue, and it promotes rapid 
anastomosis [1, 23]. These in vitro prevascularized scaffolds are not, however, surgically attached to 
host vasculature. This severely limits the diffusion and perfusion rates of these scaffolds, as pre-built 
vasculature often does not develop a physiologically relevant vascular network able to diffuse up to 
200µm [1]. This is opposed to the in vivo prevascularized scaffolds. The in vivo technique involves 
surgically inserting a scaffold into non-ischemic tissue within the host without cells and allowing it to 
vascularize in vivo [1]. The scaffold is then removed and reinserted into the damaged tissue. The 
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vasculature built this way has a wider spread and vascularizes the implant more completely. 
Unfortunately, this is a slower process and requires three surgeries to implant into ischemic tissue [1]. 
 Another cell based vascular engineering strategy involves the induction of neoangeogenesis in 
vitro. The use of growth factors promotes vessel formation, cell assembly, and migration of endothelial 
cells [1]. These growth factors, including vascular endothelial growth factor (VEGF), basic fibroblast 
growth factor (bFGF), hepatocyte growth factor-regulated tyrosine kinase substrate (HGS), platelet 
derived growth factor (PDGF), transforming growth factor beta (TGFbeta), and angiopoietin, initiate this 
host derived vascularization and can be applied directly to the site that needs them most [1]. 
Unfortunately, these growth factors, once applied to the desired site, are both highly unstable and 
difficult to control [1]. Improvements in biomaterials, such as poly lactic-co-glycolic acid (PLGA) and 
polylysine (PLL), have improved the delivery of these growth factors, but it remains an imperfect system 
[1]. 
 The use of cell sheets in vascular engineering has shown significant promise on several fronts. It 
involves the culture and then careful removal of monolayers of cells from temperature sensitive plates 
in a bioreactor. Thermoresponsive plates change hydrophobicity with external temperature, allowing 
cells to lift off the surface in sheets. The cell sheets can then be layered or shaped as desired [1, 5]. 
Structures made with these cell sheets have very good mechanical properties and show promise as a 
method of pursuing scaffold free vascular tissue engineering [5]. Unfortunately, this is limited as well. 
The cell sheets take a very long time to mature within their bioreactors and are difficult to remove 
without tearing [5]. Additionally, while cell sheets do show promise for scaffold free engineering. There 
is still no reliable method to make these custom shaped tissues with any degree of reproducibility, 
speed, or precision [19]. 
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2.3.3: General Limitations of Vascular Engineering 
 In the previous subsection, the benefits and limitations of multiple vascular engineering 
strategies were discussed in depth. While understanding limitations of individual strategies is important, 
it is also vital to discuss what is limiting the field of vascular engineering and what has not yet been fully 
addressed. First and foremost among these is that there is no perfect material for vascular tissue 
engineering [7]. Whether it be due to a mismatch of mechanical properties, poor cell integration, 
immune reaction, or other factors, all polymers and natural materials have shortcomings [1, 7]. There 
are also additional factors that affect remodeling in ways that are not fully explored and understood, 
such as shear stress, stretch, immune response, and the specific properties of each matrix [7]. Cells are 
also a major limiting factor. The cells used in vascular engineering must be renewable and functional, as 
well as capable of rapid proliferation with minimized immune response [7], [5]. Additionally, it has been 
found that the endothelial cells seeded onto synthetic grafts are only 10% as functional as their native 
tissue counterparts, and tend to experience premature senescence [7]. Limitations with vascular 
engineering are varied, from material properties to reproducibility to cell functionality, but it is still a 
wide and important field of study for the treatment of a multitude of dangerous and debilitating 
conditions. 
2.4: Microfluidics for Vascular Modeling 
Besides the need for engineered vascular tissue, a considerable amount of work is being done to 
build a reliable vasculature model in vitro. These models became extremely popular with the 
introduction of polydimethylsiloxane (PDMS) [24]. PDMS is optically clear, relatively simple and 
inexpensive to work with, non-cytotoxic, and capable of precisely and accurately molding to patterns on 
a micron scale through soft lithography. It is the current state-of-the-art and most popular platform for 
microfluidics [24]. In the realm of vasculature, microfluidics primarily focus on reconstructing blood 
vessels in vitro to study vasculature in relation to disease modeling, drug screening, and small scale 
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versions of full vascular environments [2]. Microfluidic models of vascular networks can be created in 
several different ways to fulfil the requirements of each application. 
2.4.1: Microfluidic Techniques for the Creation of Vascular Models 
 The most common techniques used for vascular modeling in microfluidics are cell patterning, 
patterned microchannels, sacrificial molds, and self-assembly. These techniques (pictured in Figure 3 
below) each provide different benefits to the user and have seen considerable success in vascular 
engineering. 
 
Figure 3:Schematic of vascular microfluidics fabrication methods. (a) Cell patterning within a PDMS device (b) sacrificial 
channels in hydrogel (c) patterned microchannels (d) self-assembled vasculature within a hydrogel matrix. Adapted from Kim et 
al. by Hugh Long 
 
Cell patterning is among the simpler methods of vascular microfluidics and is most frequently 
used for studying shear forces on endothelial cells and diffusion through lined membranes [2]. A nano-
scaled pattern is created using photolithography and imprinted into PDMS through soft lithography [2]. 
The PDMS can then be treated to be capable of cell culture, and cells can be grown directly onto the 
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patterns created through the soft lithography, and multilayered devices can be made to establish flow in 
cell seeded channels [2]. This method is also versatile enough that it is not limited to PDMS alone. 
Channels can be lined with a variety of patterned polymer membranes to achieve similar effects [2, 25]. 
The Stroock lab, for example, has patterned microchannels onto calcium alginate gel using PDMS, then 
combined two alginate layers by holding them together using an aluminum rig and injecting the material 
with primary chondrocytes. This system was then used to calculate diffusion through cell seeded bulk 
material [26].  Cell patterning is a simple technique to learn and utilize, and it is high throughput, making 
it ideal for a lot of researchers. 
 Patterned microchannels are made in a similar fashion as the cell patterned microfluidic devices 
but used for different applications. Patterned devices are made using PDMS soft lithography and layered 
together [2]. Channels are then typically filled with cell seeded hydrogels [2]. Cells can then be 
stimulated to grow in the desired alignment to the desired size within the hydrogel [2]. Stimuli within 
the channels are highly controllable, thus making this technique capable of reproduceable vasculature, 
and has made fully patent and confluent endothelialized channels within layers of PDMS[27]. This ease 
of use makes the method high throughput as well [2]. This method of microfluidic vascular engineering 
also shows considerable promise as it is capable of being translated to various hydrogels and 
biomaterials, such as collagen and polylactic glycolic acid (PLGA) [2, 28].  
 Another popular method of channel formation for vascular microfluidics involves the use of a 
sacrificial mold, or a sacrificial structure. Sacrificial structures are designed to create space within a 
hydrogel or other material and be removed immediately prior to cell seeding, leaving behind channels of 
predetermined dimensions [2]. It is common to secure those spaces with needles or rods within the 
hydrogel base. It is also common to use gelatin as a sacrificial structure. Gelatin has the added benefit of 
being able to be molded into a variety of shapes [2, 24, 29]. Sacrificial molds also promote the usage of 
materials besides PDMS for the bulk of the microfluidic device. The Chen lab uses sacrificial structures 
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made from micropatterned gelatin, which are placed against a treated glass slide and casts collagen gel 
over the surface within a larger PDMS mold in order to make complex channels against the surface of 
the glass [30]. A similar method has been used in the Tien lab where gelatin based meshes were 
fabricated as narrow as 6 µm in width [29].  In some cases, such as in work done by the Kaplin lab, 
complex multichannel networks can be made without the use of additional PDMS to encase the 
hydrogel fluidic device. In this instance, complex sacrificial structures were encased in multiple layers of 
silk hydrogel to obtain a self-contained network of channels [24]. 
 Self-assembly of microfluidic vasculature is much different from the other methods discussed 
above. In self-assembly, vascular growth is not guided by structures [2]. Endothelial cells are simply 
seeded inside of a hydrogel matrix and allowed to grow themselves [2]. This is controlled only by growth 
factors and signals, and the vasculature grown using this method is the most physiologically similar to 
native tissue [2]. Coculturing different cell types can mimic several different physiological 
environments[2]. It is, however, very difficult to work with due to the necessity for extreme control of 
the experiment at all times. It has, however, been successful in vitro. The George lab at UC Irvine has 
proven the viability of this method by seeding human umbilical vein endothelial cells (HUVECs) onto 
microbeads and embedded them into a fibrin gel matrix. Assisted by signaling from media and a 
monolayer of dermal fibroblasts, the HUVECs sprouted capillary networks[11]. This experiment was 
done to facilitate the creation of a complex, prevascularized, anastomosing capillary network, as well as 
to observe the diffusion of oxygen through thick hydrogel layers [11]. 
 Each of the methods discussed above provide different benefits and vascular environments for a 
wide range of research applications. 
2.4.2: Applications of Vascular Microfluidics 
 Currently, there are only very limited in vivo applications of the vascular microfluidic techniques 
discussed above. The field is more focused on in vitro studies to increase understanding of various 
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diseases, both vascular based and cancer, how various drugs interact with vasculature, and the 
development of organ on a chip technology [2]. The advent of vascular microfluidics has made each of 
these areas of interest easier to study in vitro and allowed for greater understanding. 
 Engineered vascular networks are especially useful for the study of endothelial dysfunction, or 
malfunctions in the vascular wall [2]. It allows the observation of underlying principles of this endothelial 
dysfunction to gain a better understanding of its causes without the need to induce disease within an 
animal model. In vitro study of endothelial inflammation has given scientists and engineers a model for 
how vascular dysfunction impacts blood flow, and how that change in flow impacts the permeability and 
thrombotic factors of the endothelium [2]. Findings from the use of vascular microfluidics include the 
process by which atherosclerotic lesions and thrombus formation occur at points of endothelial 
inflammation [2]. By making a viable model for endothelial dysfunction in vitro, it has allowed for a 
deeper understanding of dangerous vascular diseases without the complications and ethical concerns 
involved in the use of in vivo animal models. 
 When a tumor forms, the blood vessels in the surrounding environment go through a series of 
changes, altering the surrounding microenvironments, and connecting to the tumor, simultaneously 
feeding it and promoting metastasis [2]. Before the advent of vascular microfluidic models, it was very 
difficult to study tumor angiogenesis in vitro [2]. Now, it is commonplace to observe and measure this 
process by coculturing tumor cells with endothelial cells within a microfluidic network. This is especially 
useful because it allows for the observations of how processes change in different microenvironments, 
in reaction to various signals in differing concentrations, and the process of proliferation [2]. Having 
vascular microfluidic devices has allowed for a much deeper understanding of cancer metastasis and 
allowed for all of this to happen in small scale environments, which again reduce the need for animal 
models. 
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 As discussed, vascular microfluidic models provide a platform to study diseases. One of the 
greatest benefits of these models is that they can also be used as drug screening models. The 
vasculature contained within a microfluidic device can be exposed to a large number of drugs at a high 
throughput all within a small, contained environment, and the behavior of the cells can be observed in 
real time [2]. Because the vasculature in this environment is contained, and many can be manufactured 
at one time, it is possible to measure different doses and treatment times of a variety of drugs at once 
[2]. This is especially popular for anti-cancer compounds where dosage and exposure time needs to be 
precise to prevent unintended toxicity. Microfluidic drug screening also allows observation of the 
efficacy of different drug delivery methods [2]. The ability to simulate healthy and diseased vasculature 
in vitro with microfluidic networks has made drug screening, while still difficult, a much more 
streamlined process. 
 All of the above applications combine into one in the form of organs on a chip. The vascular 
microenvironments of different organs and tissues, including bone, kidneys, arterial tissue, lung tissue, 
skin, cardiac tissue, liver tissue, skin, the blood brain barrier, and the lymphatic system, can all be 
mimicked through very careful control of the microfluidic channels and the coculture of various cell 
types [2]. This is a very difficult and precise process, but it is possible to make systems biologically similar 
enough to all of these physiological environments to be able to study diseases, tumor metastasis, and 
test drugs within each of the specific environments to observe biological reactions within different 
microenvironments [2]. 
 The multiple and varied applications of in vitro vascular modeling have been vital to establishing 
our understanding of vascular disease and how to treat it, and it has proven an accurate model for 
several organ systems. Unfortunately, however, despite all of its benefits, microfluidic vascular models 
have several limitations. 
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2.4.3: Limitations of Microfluidic Vascular Models 
 As previously mentioned, microfluidic vascular models are almost exclusively used in vitro. This 
is primarily because of the materials most commonly used to make the devices. PDMS is an extremely 
useful material due to its optical clarity, ease of use, and ability to pick up patterns on the nanometer 
scale using soft lithography, and, as previously mentioned, it is the gold standard for nearly all 
microfluidics research [2]. It is not, however, a particularly useful biological material. PDMS cures at high 
temperatures during manufacturing, which prevents the combination of PDMS with any biological 
factors [24]. It is also not particularly conducive to either cell infiltration or attachment, meaning that 
bioactivity of PDMS is very limited without surface treatment [24]. PDMS is also not degradable in vivo, 
meaning that it is not an ideal material for remodeling or for in vivo implants [24]. 
 Some of the microfluidics methods mentioned in Section 2.4.1: Microfluidic Techniques for the 
Creation of Vascular Models above discuss the possibility of using non-PDMS materials, such as natural 
biomaterial hydrogels. Microfluidic devices with bases of gelatin, agarose, collagen, and other ECM 
proteins have all been developed and tested, and see much better biofunctionality than PDMS [24]. 
These hydrogels, however, tend to be much more difficult to work with. The lack of mechanical stiffness 
and strength means that only very simple vasculature can be developed within these matrices [24]. 
Another limitation observed with the use of hydrogels as a 
microfluidic matrix is the prevalence of leakage between layers. 
Traditional plasma bonding is not possible with these materials, so 
methods such as enzymatic reactions, biomaterial based glues, 
chemical and UV crosslinking, and differential casting have been used 
to seal layers with varying levels of success [6, 24]. Poorly bonded 
layers in microfluidics, especially vascular microfluidics, compromise 
the integrity of the perfusion, and can cause device failure, such as in 
Figure 4: Example of leakage from poorly 
bonded hydrogel layers. Taken from 
Borenstein et al. [7] 
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Figure 4. Overall, the field of vascular microfluidics is rapidly developing, and has seen great success in 
many applications. While it is not capable of widespread in vivo implantations yet, it has proven an 
incredibly valuable tool for the study of physiologically similar vasculature in vitro. 
2.5: Project Materials 
 This section includes a brief discussion of the two materials most prevalently used in this thesis: 
fibrin and gelatin. 
2.5.1: Fibrin 
 
Fibrin, the structure of which is shown in Figure 5 is a natural biopolymer created by thrombin 
cleaving fibrinopeptides A and B from fibrinogen, creating the matrix which makes up the bulk of blood 
clots [31]. Fibrin is a popular biomaterial in regenerative medicine. This is primarily because of fibrin’s 
considerable remodeling potential and ability to improve the survival rate of implanted cells [32]. Fibrin 
implanted directly into wounds has shown significant promise for improved regeneration and healing. 
Grafts implanted into venous tissue have consistently showed considerable ingrowth of elastin and 
remained patent at 12 weeks, and fibrin injected into ischemic cardiac tissue has reduced the expansion 
Figure 5: Structure of fibrin. Adapted from Sigma Aldrich by Hugh Long 
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of infarcted tissue [5, 32]. Additionally, part of what makes fibrin especially attractive for vascular 
engineering is the fact that it induces neovascularization [32]. All of this has been successful despite 
fibrin’s generally poor mechanical properties [5]. These mechanical properties, however, are highly 
tunable. 
 Besides its natural regenerative and cell adhesive properties, another attractive property of 
fibrin is that it is highly tunable, both in mechanical and degradation properties [32]. The mechanical 
properties of fibrin are primarily controlled by the concentration of fibrinogen and thrombin, and 
modulating these factors have shown significant impact on the mechanical properties of the fibrin 
microstructure [33]. While this change in stiffness can greatly improve the mechanical properties for 
specific applications, it has also been shown to have impacts on adherent cell morphology, protein 
expression, and migration [33]. Despite this, successful modulation of fibrin porosity, stiffness, viscosity, 
and tensile strength has allowed the development of several successful products, including tissue 
sealants, growth factor and drug delivery vehicles, and cell seeded implants [33]. 
 While the concentration of fibrinogen and thrombin are used to alter the mechanical properties 
of fibrin, degradation properties are more commonly adjusted with the addition of aprotinin, a protease 
inhibitor which slows fibrinolysis [32]. The addition of aprotinin also increases the infiltration of 
capillaries and reduces the fibrous encapsulation of implanted fibrin [32]. While aprotinin is used to slow 
fibrin degradation, it isn’t possible to stop this process entirely. The degradation products of fibrin are 
not only nontoxic, but also stimulate the migration of neutrophils and monocytes to the site of fibrin 
implantation, and signals for the neutrophils to commence phagocytosis at the wound site, thus further 
promoting healing [32], [34]. 
 Overall, fibrin is an attractive material to be using for the purposes of regenerative tissue 
modeling due to its cell adhesive and regenerative properties, and viable for microfluidic experiments 
due to its highly tunable mechanical properties and architecture. 
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2.5.2: Gelatin 
 Gelatin was chosen for this project primarily because of its utility as a sacrificial material. A 10% 
weight volume solution of gelatin has multiple properties that make it highly desirable for this 
application [24]. Once a gelatin structure is made, it is highly resistant to deformation, and is able to 
preserve the patency of the formed channels, even if considerable pressure, up to 80 cm H₂O, is applied 
[29]. The material is strong enough to be made as narrow as 6µm without compromising shape or 
structure [29]. Gelatin also has a melting point below 35°C, which is well below the melting point of 
most materials used in hydrogel based microfluidics, allowing it to fully melt within the bulk gel [24, 29]. 
While these properties are all favorable for the use of gelatin, there are some drawbacks to consider. If 
gelatin is removed from a mold while not completely dry, or is rehydrated from a dried state, it tends to 
swell slightly, and not in an entirely uniform manner. This means that the channels created by gelatin 
sacrificial structures, while highly similar to each other, are unlikely to be identical [24, 29]. That being 
said, gelatin’s positive characteristics still make it highly favorable for use in sacrificial structures. 
2.6: Summary 
 To summarize this background, while a great deal has been done to combat the difficulties of 
vascularization in full thickness engineered tissue constructs, there has been no ideal method developed 
that combines the reliability of synthetic materials with the biofunctionality of natural hydrogels. While 
microfluidic models have shown great promise in vitro, current cell-, synthetic-, and natural-material-
based vascular engineering have yet to produce a reliable and functional method of perfusion. Overall, 
there is a need for an engineered vascular device that will be capable of creating reliable channel 
geometries while maintaining a functional cell population without being rejected by the body.. 
 To address this need, I propose a unique single layered fibrin vascular device which will be of a 
physiologically relevant arterial size, and capable of physiologically relevant flow and diffusion. This 
device will also have the capability to supply a cell population on the surface by diffusion from the 
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encapsulated channels. This will be done using a robust fibrin gel and a gelatin based sacrificial structure 
to create a seamless device to minimize the problem of leakage seen with other similar devices.  
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Chapter 3: Goal and Objectives 
In order to ensure cell viability within large scale, tissue engineered constructs for long term 
applications, there is a need for a method of perfusing constructs with blood or media. Due to the 
developmental and technical nature of this project, this thesis was defined by a goal and a series of 
objectives rather than a hypothesis and aims. The goal of this project was to develop a novel method 
for the fabrication of a single layered fibrin based vascular network that was able to reliably produce 
channels, had flow properties that were physiologically relevant, and had a diffusion rate that was 
capable of sustaining a viable cell population on the surface.  If successful, this project would result in 
a unique platform technology for advancement in engineered scaffolds, in vitro fabricated tissues, and 
in vitro drug testing. 
 The three objectives outlined in detail below were directed at the characterization of 
microfluidic channels within the fibrin device, establishing flow and diffusive properties of the channels 
and fibrin gel, as well as establishing the ability to maintain a cell population on the surface of the 
device. 
Objective 1: Develop a novel technique for creating a consistently sized vascular network 
within a fibrin gel matrix. 
The approach for this objective involved using a sacrificial structure encapsulated in fibrin gel in order to 
produce a branched microfluidic device without bursting or leakage. The first set of experiments to 
achieve this objective focused on developing physiologically relevant sacrificial structures to mimic small 
arteries. Small arteries were chosen because this thesis was framed as a proof of concept designed to 
address problems seen in previous iterations of this project such as leakage and continuous perfusion [6, 
35]. We decided that the best way to tackle the problems seen in previous iterations was to start with 
an easier to manufacture large scale structure capable of being scaled down in the future. 
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The next step was to create a method to consistently generate fluid flow through a block of 
fibrin using the sacrificial structure method. Once this was determined, characterization of channels 
began. This was done through imaging and measurement of the sacrificial structures. Finally, in order to 
measure channel height, devices were sectioned, imaged and measured using histology techniques. 
Averages and standard deviations were measured for each experiment and compared between the 
sacrificial structures and the produced networks. 
While a significant amount of discussion has touched on the need for microvasculature, the goal 
of this project was not to mimic those sizes exactly, but instead to work with channels the size of small 
arteries for this proof of concept developmental study. To mimic small arteries, the goal of this study is 
to achieve a channel diameter between 0.1.4 and 2.0 mm  [8, 9]. Success in this objective was defined as 
the ability to reliably produce and perfuse channels of consistent size without experiencing device 
leakage. 
Objective 2: Determine flow properties of liquids passing through the channels and the 
rate of diffusion through the gel  
 The purpose of this objective was to prove that the channels produced within the first objective 
were comparable to physiological structures. The approach for this two-part objective focused on 
perfusing channels of the fibrin vascular device with different fluids. The first set of experiments was 
used to measure the flow properties within the channels. A suspension of microbeads was perfused 
through the channels and individual particles were tracked in order to determine volumetric flow rate, 
Reynolds number, and wall shear force. Flow within native vasculature is laminar and applies enough 
wall shear force to allow endothelial cells to function normally. Proving physiological values lends 
credibility to fibrin vascular devices being used as vascular models. The second set of experiments 
targeted diffusion rates of molecules through the fibrin vascular device. One of the major functions of 
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vasculature is to diffuse oxygen and nutrients to the surrounding tissue. Determination of the diffusive 
properties was done to show that fibrin vascular devices were capable of diffusion from the channels 
into the surrounding gel. This was done by measuring the grey value of a line through the gel over the 
course of several minutes to observe changes in brightness. This was done with multiple sizes of 
fluorescent particles. Success of this objective was defined as collecting clear and accurate values for a 
variety of flow and diffusive properties and having said values fall within physiologically relevant ranges. 
Objective 3: Determine zones of cell uptake on top of the device and observe how these 
zones change over time 
 The final objective was approached by measuring cellular uptake zones on the surface of the 
fibrin vascular device. This was performed in order to prove that the fibrin vascular devices were 
capable of diffusing particles through the bulk of the gel to the surface at sufficient rate and volume to 
observe intake into live cells. The experiment done to fulfill this objective involved culturing cells onto 
gelatin coated cover slips and placing these on the surface of the fibrin vascular device perfusing live 
staining dye for several hours. Images were taken at two time points to observe changing zones of cell 
uptake. Success of this objective was defined as the ability to see fluorescent cells on the surface of the 
fibrin vascular device, and to see the area of fluorescence growing over time.  
39 
 
Chapter 4: Methods 
This section provides a thorough description of the procedures used to achieve each specific 
goal of this project. The topics discussed include the manufacture of sacrificial structures, the alteration 
of fibrin gels, the development of fluid flow within a fluidic device, the characterization of the fluidic 
channels, measurements of flow properties including flow rate, Reynolds number, and wall shear stress, 
diffusivity calculations, and viable zone identification. 
4.1: Sacrificial Structures 
This subsection is focused on the process of developing the gelatin sacrificial structures used in 
the fabrication of the fibrin vascular devices. This process included the development of the computer 
model, mold fabrication, gelatin pouring protocol, and identifying the most effective lamination 
protocol. 
4.1.1: Computer Modeling 
To design a mold for the production of sacrificial 
structures, SOLIDWORKS computer modeling software was 
used to create a basic two channel mold with evenly sized 
channels, inlets, and a divider at 2 mm wide. An isometric view 
can be seen in Figure 6 . A full drawing of the mold can be 
found in Appendix 1: SOLIDWORKS Drawing of Acrylic Mold. 
These dimensions were chosen in order to make a structure 
that would produce a size similar to small arteries. 
4.1.2: Mold Fabrication 
To convert the computer model to a usable mold, the SOLIDWORKS file was converted into an 
AutoCAD file. A Universal Laser Systems Versalaser VLS-4.60 laser cutter was used to cut several pieces 
1 cm 
Figure 6: Isometric view of SOLIDWORKS model 
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out of 3mm acrylic. These pieces 
included a flat rectangular base, a base 
with the channel shape cut out of it, the 
channel shape, and an 0.75mm thick 
wall. An additional channel shape was 
cut out of 1mm acrylic. These pieces 
were then layered together with acrylic 
glue to create a mold with a 1mm high 
raised channel shape (Figure 7). 
The mold was treated with a 
coating of 1% pluronic F-127 for one 
hour, and then filled with a 10:1 elastomer to curing agent ratio of polydimethylsiloxane (PDMS) and 
allowed to cure overnight in a 37°C oven. The 
PDMS negative was then removed. These 
PDMS molds were rectangular with a precise 
imprint of the channel structure in the 
center. This process is known as soft 
lithography (Figure 8). 
4.1.3: Sacrificial Layer Creation 
 To make single layers of gelatin, the 
PDMS molds were coated with 1% pluronic 
F-127 (Sigma P2443) for one hour. Once removed, the channels were then filled with a solution of 
melted 10% gelatin (Sigma G2500) in 1X phosphate buffered saline (PBS). All 1X PBS was diluted from a 
10X stock (OmniPur 6505) and brought to pH 7.4. Structures were allowed to dry overnight in the molds. 
Figure 8: PDMS negative mold 
Figure 7: Laser cut acrylic mold 
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It was found that structures maintained their shape best when PDMS molds were coated once per 10 
uses. 
4.1.4: Lamination Techniques 
 In order to make a structure of physiologically relevant dimensions, two gelatin layers needed to 
be laminated together. A single dehydrated sacrificial layer was found to be too thin to structurally 
support itself and was not similar to 
physiologically relevant structures. 
Structure lamination was done to 
thicken the structure to make a shape 
more similar to in vivo vasculature. Four 
methods were attempted, as shown in 
Figure 9. A structure was considered 
hydrated if the gelatin had completely 
set, and still held most of its moisture 
but was set enough to remove from the 
PDMS mold to be stacked. Dehydrated layers were defined as layers that had been allowed to dry 
overnight. Partially rehydrated was defined as a dehydrated structure allowed to soak in 1X PBS until it 
was soft enough to be malleable, but not so soft that it lost its shape. This process was controlled by 
initially soaking structures for five seconds, removing from PBS to observe pliability, and continuing to 
soak in two second intervals until desired point was reached. The gelatin glue used was melted 10% 
gelatin that had not yet been allowed to set. Lamination strategy A was performed by removing two 
hydrated structures from their molds and laying one on top of the other with no additional adhesive. 
Strategy B was also fabricated from two hydrated structure, but 0.05 mL of gelatin glue was spread over 
the full surface of the bottom structure using a syringe and a 20-gauge needle before the other structure 
 Figure 9: Lamination strategies. (A) Two stacked hydrated layers (B) Two hydrated 
layers with gelatin glue (c) Two dehydrated layers with gelatin glue (D) One 
dehydrated layer and one layer partially rehydrated in 1X PBS 
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was placed on top. Lamination strategy C was performed very similarly to strategy B, but structures 
were allowed to dehydrate overnight before lamination. Finally, lamination strategy D involved partially 
rehydrating one gelatin layer and placing it on top of a dehydrated gelatin layer and allowed to dry 
again. 
4.1.5: Final Structure Fabrication 
 To make gelatin sacrificial structures, we developed the process shown below in Figure 10.The 
PDMS negative was filled with pluronic F-127 for one hour, which was then removed and replaced with 
10% gelatin. The gelatin was allowed to dry overnight on the bench top and was then removed from the 
mold. Two structures were laminated together and dehydrated again on the benchtop. Any poorly 
shaped sacrificial structures were partially rehydrated and left to dehydrate again under a thin piece of 
PDMS. All dehydrated structures were stored at room temperature. 
 
E D 
C B A 
10 
mm
Figure 10: Fabrication of a sacrificial layer (A) PDMS mold (B) Pluronic F-127 coating (C) Filling with 10% gelatin (D) Dehydrating structure 
overnight (E) Laminating two layers together 
43 
 
4.2: Fibrin Fluidic Devices 
The first part of Objective 1 was to fabricate and perfuse a fibrin based vascular device. This 
section details how this was done. The three subsections discuss the formulation of a robust fibrin gel, 
the building of a vascular device, and finally how fluid flow was initiated. 
4.2.1: Fibrin Gel 
To ensure the structural integrity of the fibrin vascular channels, we altered the formulation of 
our fibrin gel to better maintain its shape. Increased fibrinogen and thrombin concentrations have 
independently been shown to increase gel stiffness [33]. Several gel formulations were tested, shown in 
Table 1: Fibrin Hydrogel Formulations below. Batches of each formulation were poured onto 1% pluronic 
F-127 treated PDMS and a vellum frame to see how well they maintained shape and structure once 
removed. 
Table 1: Fibrin Hydrogel Formulations 
Component Formulation A Formulation A2 Formulation B Formulation C Formulation D
Bovine Fibrinogen    
(MP 0882021/ 
Sigma F8630)
670 µL of 9.65 
mg/mL solution in 
HBS
670 µL of 9.65 
mg/mL solution in 
HBS
290 µL of 11 
mg/mL solution in 
HBS
290 µL of 70 
mg/mL stock
500µL of 70 
mg/mL stock
Thrombin (Sigma 
Aldrich 9002-04-
4)
100 µL of 2.35 
units/mL solution 
in HBS
100 µL of 4.7 
units/mL solution 
in HBS
40 µL of 40 
units/mL stock
40 µL of 40 
units/mL stock
150µL of 40 
units/mL stock
CaCl₂               (EM 
Science CX0130-
1)
80µL of 40 
Mmolar stock
80µL of 40 
Mmolar stock
N/A N/A
60µL of 40 
Mmolar stock
1x PBS 150µL 150µL N/A N/A 112µL
DMEM             
(Gibco 11960-
044)
N/A N/A 670µL 670µL N/A
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4.2.2: Fibrin Fluidic Devices 
To provide a final platform for future experiments, we created fibrin vascular devices with the 
most favorable fibrin gel formulation. This multistep process began with the creation of a PDMS well. 
This well is a 
standard 10:1 
PDMS elastomer 
to curing agent 
ratio poured into 
a 1% pluronic 
treated 3.5cm 
petri dish over a 2cm x 1.5cm x 0.3cm block of acrylic and allowed to cure at 37°C overnight. The next 
three steps, outlined in Figure 11 , involved piercing the edges of a sacrificial structure with two 27-
gauge needles, encasing the structure in fibrin gel, and allowing it to polymerize on the bench top for 30 
minutes. 
4.2.3: Fluid Flow Initiation and Continuous Perfusion 
To create channels within the device, the sacrificial structure was melted and removed. After 
the fibrin gel polymerized around the gelatin sacrificial structure, the block was removed from the PDMS 
well and moved into a petri dish with 3 mL of 1X PBS. The petri dish was left in a 37°C incubator for at 
least 30 minutes. 
During this time, 
the gelatin 
structure 
hydrated and 
melted within the fibrin block. As shown in Figure 12, the melted gelatin could then be removed. The 
 
Figure 12: The removal of a gelatin sacrificial structure from within a block of fibrin gel. (a) Incubated 
vascular device with intact gelatin structure (b) Fluid pushed through fibrin vascular device, removing gelatin 
structure 
Figure 11: The fabrication of a fibrin vascular device. (A) The pierced sacrificial structure suspended in a 
PDMS well (B) 70 mg/mL fibrin was poured over the sacrificial structure. Any resulting bubbles were 
removed (C) Fibrin polymerizes around the structure 
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sides of the device were pierced with a 20-gauge needle, and the gelatin was flushed out with 1mL of 
the warm PBS, in which the device had been incubated. 
Once the gelatin had been removed, continuous perfusion was achieved with a syringe pump 
(Cole-Parmer 74902-00). A syringe filled with the desired liquid was tipped with custom microfluidic 
tubing. The polyethylene tubing was 16cm long with an inner diameter of 0.86mm (Intramedic 427421), 
with a flat-tipped 20g needle inserted 0.75cm into one end, and the removed tip of a second flat-tipped 
20g needle cut to 1.25cm inserted into the other end. One of these pieces of tipped tubing was attached 
to the syringe in the syringe pump. A second piece of this custom tubing was attached to a syringe full of 
diH2O. This was used to make drop-to-drop contact with the liquid within the channels of the fibrin 
vascular device in order to maintain a fluid gradient without bubbles. Once this was connected, the 
syringe pump was started and allowed to flow at 0.75 mL/ hour until a drop appears at the end of the 
tubing. This was then inserted into the other end of the fibrin device. The syringe not attached to the 
syringe pump was then removed and the tubing was allowed to flow into a waste container. 
4.3: Channel Characterization 
The second major part of Objective 1 was to verify the fidelity of the sacrificial structures, as 
well as to establish channel geometry. This subsection looks at how the structures were characterized 
morphologically along the x- and y-axes, as well as in the cross-sectional area. It also details the 
histology performed to measure the resultant channels. Finally, it covers what statistical analysis was 
performed to compare the structures and the channels. 
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4.3.1: Sacrificial Structure Characterization 
To determine the average size of the gelatin sacrificial structures, 
photographs of 20 sacrificial structures were taken next to a ruler used as a 
scale bar. Structures were then measured using the imaging software 
ImageJ along several points, shown in Figure 13 to the right. 
Measurements were averaged across the samples with standard 
deviations.  
4.3.2: Sacrificial Structure Cross-Sections 
To measure the sacrificial structure cross sections, a PDMS disc was made in a 3.5cm petri dish 
and cured overnight. The disc was removed 
and a shallow cut was made in the center of 
the disc. Sacrificial structures were snapped 
in half until there were seven intact 
samples. Samples were mounted within the 
PDMS disc, and the ends of each channel 
and inlet were photographed on a AmScope 
FMA050 stereoscope with a Basler acA1920-
50gc camera (Figure 14). A calibrated scale 
bar image was taken at the same magnification. Images were scaled according to the calibrated scale 
bar, and the height, width, and area were each measured using ImageJ. Calculations were made to 
exclude outliers, and means and standard deviations were calculated for each measurement (𝑛 = 21).  
Figure 13: Measured points of a sacrificial 
structure. (1) end to end (2) width (3,4) inlet 
and outlet width (5,6) channel width (7,8) 
crossbar width (9,10) divider width 
Figure 14: Cross sectional imaging of sacrificial structures. (A) Side 
view and (B) top view of structure inlet or outlet. (C) Side view and 
(D) top view of structure channels. 
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In ImageJ, measurements were taken from corner to corner on all four sides (Figure 15). The sacrificial 
structures were not necessarily 
even throughout each cross 
section. For this reason, both 
height measurements and both 
width measurements were 
taken and averaged for each 
observed structure to reach a 
measured value. Quartile 
calculations were performed to 
remove all outliers from height 
and width measurements. Due to the non-uniform rectangular shape, area measurements were 
calculated both by multiplying height and width, as well as by tracing the outer edge of the sacrificial 
channel 
4.3.3: Histology 
This experiment was performed to measure the dimensions of the channels resulting from the 
removal of the gelatin sacrificial structures. Fibrin vascular devices were perfused to remove the 
sacrificial structures and were then fixed in 10% neutral buffered formalin (NBF) for one hour. The 
devices were then rinsed in PBS three times for five minutes each. All NBF and PBS used in the rinses 
were disposed of in a hazardous waste bottle. The samples were then cut into quarters along the long 
edge and each quarter was placed into a nylon tissue specimen bag (Thermo Scientific 6774012). The 
specimen bags were folded gently and placed into plastic tissue cassettes. The cassettes were loaded 
into a Tissue-Tek VIP® 6 AI tissue processing machine on a “Short No Fix” cycle, detailed  in Table 2 
below. Samples were removed the next morning and embedded on a Leica EQ 1160 embedding table. 
Figure 15: Representative image of sacrificial structure cross section with lines of 
measurement 
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Table 2: Short No Fix Cycle 
Step Bath Time Step Bath Time
1
70% 
Ethanol
30 
minutes
7
100% 
Ethanol
20 
minutes
2
80% 
Ethanol
30 
minutes
8 Xylene
30 
minutes
3
95% 
Ethanol
20 
minutes
9 Xylene
20 
minutes
4
95% 
Ethanol
20 
minutes
10 Xylene
20 
minutes
5
100% 
Ethanol
20 
minutes
11 Paraffin
30 
minutes
6
100% 
Ethanol
20 
minutes
12 Paraffin
30 
minutes  
Table 3: Eosin Staining 
Step Bath Time Step Bath Time
1 Eosin
1 
minute
5
100% 
Ethanol
1 
minute
2
95% 
Ethanol
1 
minute
6 Xylene
2 
minutes
3
95% 
Ethanol
1 
minute
7 Xylene
2 
minutes
4
100% 
Ethanol
2 
minutes
8 Xylene
2 
minutes  
Blocks were then sectioned on a Leica RM2235 microtome at 8µm. These sections were placed 
in a warm water bath and collected onto charged slides (VWR 48311-703). Slides were deparaffinated by 
constant movement in two five-minute xylene washes, followed by two three-minute 100% ethanol 
washes. The slides were dried thoroughly between each wash. The slides were then stained with 
alcoholic eosin with phloxine (Sigma HT110332) according to the bath and time information in Table 3 
above. The sections were then covered with cover slips using Cytoseal 60 cover slipping medium 
(Thermo Scientific 8310-4). Ten slides were made of each well-formed channel. 
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 Slides were observed and photographed at 5X-magnification on a Leica DMIL LED inverted 
microscope with an Image source DFK 41BU02 camera. A calibrated scale bar image was also taken at 
this time. Images were scaled according to this scale bar and analyzed using ImageJ. The length and 
width were measured according to the clearest visible corners (Figure 16), and the area was taken both 
by measuring around the outside of the channels, and by multiplying the measured length and width. 
The ten slides were averaged, and the standard deviation was found for the seven channel samples. 
4.3.4: Statistical Analysis 
To compare channel size to the size of the cross-section of the sacrificial structure, a student’s t-
test was run using the means and standard deviations of the lengths and widths of the samples. 
Statistical significance was defined as a P value of P < 0.05. 
4.4: Flow and Diffusion Properties 
This subsection focuses on the second objective. This involved calculating flow properties, 
including flow rate, Reynolds number, and wall shear force. Physiological blood flow in small arteries 
Figure 16: Histological section of fibrin vascular device with lines of measurement 
50 
 
have a mean flow rate of 3.5 mm3/s, but can be as low as 0.04 mm2 /s ,and exhibit laminar flow, so our 
system targets properties in this range [32]. This section also covers quantification of the diffusivity of 
macromolecules through the fibrin vascular device. 
4.4.1: Microbead Flow Analysis 
To determine flow properties within the fibrin channels, three fibrin vascular devices were 
perfused at 0.75 mL/hour by a Cole-Parmer single syringe infusion pump with 1X PBS and with a 
suspension of 6µm polystyrene beads (Polysciences Inc. 15714). The tubing connecting the 1 mL syringe 
to the fibrin vascular device was 16cm long with an inner diameter of 0.86mm (Intramedic 427421), with 
a flat-tipped 20g needle inserted 0.75cm into one end, and the removed tip of a second flat-tipped 20g 
needle cut to 1.25cm inserted into the other end. Waste tubing was identical and led from the outlet of 
the fibrin vascular device to a 100 mL beaker full of diH20. The 6 µm bead size was chosen to mimic the 
size of neutrophils, which travel through vasculature. Six 15-second-long videos were recorded on a 
Nikon SMZu stereoscope at 20X with a Spot INSIGHT CMOS camera. Videos were taken as a series of 
time lapse images captured at an average of 6 frames per second. A calibrated scale bar image was 
taken at the same magnification, and all videos were scaled accordingly. 
ImageJ was then used to track the distance traveled by ten particles in each video. These 
distances were recorded and averaged per video, as well as overall.  
4.4.2: Determining Parabolic Flow 
In this section, the parabolic nature of the flow within the fibrin vascular devices was measured 
to determine if the flow patterns within the fibrin vascular channels mirrored the parabolic properties of 
native tissue.  
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To calculate parabolic flow, the average width of 
each individual microfluidic channel was 
measured and split into six even regions (Figure 
17). The measured particles were put into 
regions based on their distance from the top of 
the channel. The average velocity of particles in 
the top three regions was calculated over the 15 
second video, and particles in each region were averaged. 
 
4.4.3: Flow Property Calculations 
 Three different calculations were performed to determine the flow properties within the fibrin 
vascular device. The first calculation run was to determine the volumetric flow rate, using Equation 1 
below, where Q is volumetric flow rate, v is mean flow velocity, and A is channel area. For this equation, 
we assumed the area was the mean channel area determined in the first objective.  
Equation 1: Volumetric Flow Rate 
𝑄 = 𝑣 ∙ 𝐴 
 The next calculation done was a Reynolds Number calculation to determine the turbulence of 
the flow. The equation can be seen below in Equation 2 Equation 2, where ρ is density of the fluid, 1000 
kg/m2, v is the velocity of the fluid, L is the length of the channel, and µ is the viscosity of the fluid, 1.0 
N.s/m. Any Re value under 2300 is considered laminar flow. For this equation, we need to assume that 
density and fluid viscosity are constant. 
Equation 2: Reynolds Number 
𝑅𝑒 =
𝜌 ∙ 𝑣 ∙ 𝐿
𝜇
 
(2) 
(1) 
Region 1 
Region 2 
Region 3 
Figure 17: Regions of Analysis for Parabolic Flow 
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 The last calculation made was wall shear stress, shown in 3Equation 3. For this equation, we 
assume a no slip boundary condition, and that we have laminar flow. 
Equation 3: Wall Shear Stress 
𝜏 = 𝜇
𝑑𝑢
𝑑𝑦
 
Which can be derived to Equation 4 Equation 4, where τ is wall shear stress, µ is the viscosity of the 
fluid, umax is the maximum speed, y is the distance from the location at which the fluid moves at 
maximum speed and the wall, and h is the height of the channel.  
Equation 4:Wall Shear Stress Derivation 
𝜏 =
−8 ∙ 𝜇 ∙ 𝑢𝑚𝑎𝑥 ⋅ 𝑦
ℎ2
 
The particle speed tracked in this experiment gives us an average value rather than an absolute 
maximum. In order to account for this, I used the average function value, Equation 5 , to solve for my 
velocity in the center of the channel, where, due to laminar parabolic flow, we assume flow was the 
fastest. In this equation, a is -h/2, b is h/2, where h is the channel width. 
Equation 5: Average Function Value 
𝑓𝑎𝑣𝑔 =
1
𝑏 − 𝑎
∫ 𝑓(𝑥)𝑑𝑥
𝑏
𝑎
 
The equation in relation to particle speed is shown below in  Equation 6where u is particle speed, h is 
channel width, and y is distance from the center of the channel.  
Equation 6: Average Function Value in Reference to Particle Speed 
𝑢𝑎𝑣𝑔 =
1
ℎ
2 −
−ℎ
2
∫ 𝑢𝑐𝑒𝑛𝑡𝑒𝑟 (1 −
4𝑦2
ℎ2
)𝑑𝑦
ℎ
2
−ℎ
2
 
By solving this integration (the steps of which can be seen in Appendix 2: Maximum Particle Speed 
Formula Integration) we arrive at Equation 7 Equation 7 [36]. 
(5) 
(4) 
(3) 
(6) 
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Equation 7: Particle Maximum Speed 
𝑢𝑐𝑒𝑛𝑡𝑒𝑟 =
3
2
𝑢𝑎𝑣𝑔 
 
4.4.4: FITC-Dextran Diffusion 
 Diffusivity of the fibrin vascular devices was measured by perfusing devices with different 
molecular weights of fluorescein isothiocyanate-dextran (FITC-dextran). Two molecular weights, 40 kDa 
(SigmaFD40S) and 250 kDa (Sigma FD250S), were used to see a difference in diffusion rates between 
macromolecules of different sizes. While a direct comparison cannot be made due to molecular shape, 
the 40 kDa dextran was meant to represent small proteins and molecules, such as albumin, and the 250 
kDa dextran was meant to mimic larger molecules, like globulins. Perfusion was set up identically with a 
flow rate of 0.75 mL/hour by a Cole-Parmer single syringe infusion pump. The tubing connecting the 1 
mL syringe to the fibrin vascular device was 16cm long with an inner diameter of 0.86mm (Intramedic 
427421), with a flat-tipped 20g needle inserted 0.75cm into one end, and the removed tip of a second 
flat-tipped 20g needle cut to 1.25cm inserted into the other end. Waste tubing was identical and led 
from the outlet of the fibrin vascular device to a 100 mL beaker full of diH20. Fluorescent time lapse 
videos were recorded for 18 minutes with a Spot INSIGHT CMOS camera on a Nikon Eclipse E600 upright 
microscope at 2X-magnification. Images were taken once every 30 seconds. Three fibrin vascular devices 
were perfused with each molecular weight. Videos were calibrated using the SPOT software (SPOT54B). 
 The videos were moved to ImageJ for analysis. They were calibrated within the SPOT software 
and appropriate scale bars were added. Images where the channel was changing position or perfusion 
was not yet complete were removed from the stacks. The videos were normalized by measuring the 
average brightness in two 50x50 pixel squares 500µm on either side of the channel edges at the center 
point of the video. The average of the two means was rounded to the nearest whole number and the 
minimum brightness of the videos was adjusted accordingly. To measure diffusion on each video, three 
(7) 
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lines were drawn across the channels, covering the full width of the channel and 500µm on either side. 
The brightness profile was taken for each image in the stacks and recorded. These values were then 
graphed. If any section of the graph hit the saturation point, the dataset was excluded. 
4.4.5: Intensity Curves and Diffusivity Calculations 
  
 Intensity curves were graphed to observe the changing fluorescent intensity at the channel 
edge, and at 0.01 cm increments away from the edge. The intensity ratio, calculated as the left-hand 
side of Equation 8 below, at each time was plotted in relation to these distances to observe how the 
passing time impacts the concentration at each point.  
Diffusivity was calculated using Equation 8  below, derived from Fick’s law of diffusion. Here, CA 
is defined as the measured brightness at a certain point, CA0 is the brightness at time zero, CAS is the 
mean brightness of the surface of the channel, erf is the error function, x is the distance from the 
channel surface, DAB is the diffusivity, and t is time. Assumptions and boundary conditions for the use of 
this equation include that the channel intensity is consistent, we assume that the other boundary has a 
value of zero, flow is constant, and because we never reach out outer boundary, we can assume that it 
is an infinite system for the sake of these calculations.  
  
Equation 8: Diffusivity Equation 
𝐶𝐴 − 𝐶𝐴0
𝐶𝐴𝑆 − 𝐶𝐴0
= erfc⁡(
𝑥
√4𝐷𝐴𝐵𝑡
) 
 This equation was solved for diffusivity at five different distances from the channel edge in 
0.01cm increments.. The inverse error function was computed in Microsoft Excel as the square root of 
the inverse gamma function[37]. 
(8) 
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4.5: Cell Uptake 
This final subsection details how cell viability was assessed on the surface of the fibrin vascular 
device according to the final objective. It covers how cell culture was performed as well as the 
experiment used to establish and measure viability. 
4.5.1: Cell Culture 
To measure cellular uptake over time, a culture of cells was needed for use in uptake 
experiments. C2C12 mouse myoblasts were continuously cultured in proliferation media of 43.8% 
DMEM (Gibco 11960-044), 43.8% Hamm’s F12 Nutrient Broth (Gibco 11765-054), 10% Fetal Bovine 
Serum (INFO HERE), 1% Penicillin Streptomycin (Gibco 15140), 1% Amphotericin B (Sigma Aldrich 
A2942), and 0.4% Aprotinin (Sigma Aldrich A1153) all from stock. This media is designed to limit 
bacterial and fungal infections of cells while maintaining their ability to proliferate quickly. Cells were 
subcultured every two or three days depending on confluency. 
 C2C12 mouse myoblasts were chosen for this experiment for several reasons. First, we 
wanted a cell type that it was likely for vasculature to come in contact with. C2C12 cells being skeletal 
muscle cells made them a good candidate for this.  
4.5.2: Gelatin Coated Cover Slip Preparation 
 To obtain a cell population for cellular uptake studies, coverslips needed to be coated for cell 
adhesion. Glass cover slips were cut down to 1cm by 1cm squares using a diamond tipped pen and a 
ruler. Cover slips were then wrapped in autoclave mats, sealed in a sterilization pouch, and autoclaved 
to sterilize. The day before an experiment was to be run, sterile glass cover slips were placed into a 5cm 
petri dish, and 10µL of sterile 1% gelatin in diH20 was spread over the surface of the cover slip. The 
gelatin was then allowed to set for two hours at room temperature. At this point, 200,000 C2C12 mouse 
myoblasts and 5 mL of C2C12 proliferation media were placed into the petri dish with the gelatin coated 
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cover slips, and the plate was moved to the incubator overnight. From this process, we expect 10,000 
cells per square centimeter. This process is illustrated in Figure 18 below. 
4.5.3: Calcein AM Perfusion 
To observe cellular uptake of fluorescent dye, C2C12 cells were cultured on gelatin coated cover 
slips overnight, then washed with sterile 1X PBS twice for five 
minutes each. A fibrin vascular device was set up for perfusion 
as described in Figure 18 above. To make dye loaded media, 2 
µL of calcein AM dye (Invitrogen L3224) was added to 4mL of 
serum free media, made with 44.2% DMEM, 44.2% Hamm’s 
F12 Nutrient Broth, 10.1% HEPES buffer (Sigma H3375), 1% 
Penicillin Streptomycin, and 0.4% Aprotinin, and inverted to 
mix. The use of calcein AM dye required serum free media, as 
calcein AM, which is used as a live cell fluorescent dye due to it 
becoming cleaved upon passing through cell membranes, can 
also be cleaved when exposed to FBS. In order to ensure that 
cells would fluoresce, serum free media needed to be the perfused liquid for these experiments. 
The experiment was set up on the microscope stage. Fluid flow was initiated with the calcein 
AM loaded media, and a myoblast seeded cover slip was inverted onto the top surface of the vascular 
Figure 18: Myoblast seeded cover slips. (A) cover slips coated with gelatin (B) gelatin coated slips allowed to set for two hours 
(C) 200k C2C12 mouse myoblasts and C2C12 proliferation media added to plate (D) myoblast adhesion to gelatin coated cover 
slips 
Figure 19: Experimental setup for calcein dye 
perfusion. (a) Fibrin vascular device being 
perfused with calcein loaded media (b) 
myoblast seeded cover slip placed on surface of 
fibrin vascular device (c) device perfused for 
four hours 
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device as in Figure 19Fluorescent and brightfield images were taken with a Spot INSIGHT CMOS camera 
on a Nikon Eclipse E600 upright microscope at 4X-magnification at t=one hour and t=4 hours. Images 
were properly scaled, and the size of fluorescing zones were measured using ImageJ. Positive controls 
for this experiment took the form of gelatin coated cover slips allowed to sit in calcein loaded media for 
four hours, with images taken at the same time points as for the perfusion study. 
4.5.4: Image Processing and Calculations 
 Images were processed similarly to the fluorescent diffusion videos. Color channels were split, 
blue and red were discarded, and green was measured and normalized, as calcein AM is optimally 
excited at a wavelength 495nm. Images were normalized by drawing two 100x100 pixel boxes, one 
inside and one outside of the channel, being careful not to capture any cells within the boxes. The 
average brightness of those two boxes was taken and averaged together before that value was made 
the minimum brightness of the image. 
 For analysis, the channel edge was marked on each image, and the area of cell spread on the 
outside of the channel was measured, as in Figure 14. This area was divided by the length of the channel 
in the image to estimate the average 
diffusion plane of calcein AM dye. The 
difference between the average area 
change and the average limit of cell uptake 
were also calculated.  
Figure 20: Example of traced calcein AM diffusion curve from channel edge at 
t=1 hour 
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Chapter 5: Results 
5.1: Fluid Flow Initiation within Consistent Fibrin Vascular Devices 
 This section presents results acquired from experiments developed to achieve the first major 
objective of this project, which aimed to produce a fibrin-based device with channels capable of 
supporting continuous perfusion. The experiments in this section focused on the ability to manufacture 
and perfuse fibrin vascular devices, as well as assess the consistency of the channels within said devices. 
These experiments included: fibrin gel development, sacrificial structure fabrication and lamination, 
sacrificial structure morphometric analysis, and histological analysis of the resultant channels. 
5.1.1: Fibrin Hydrogel Formulation 
As outlined in the methods chapter, five different formulations of making a suitable fibrin gel 
were tested for the formulation of vascular devices. Results for this section were entirely qualitative. In 
order to maintain an encased channel, the 
matrix material had to be able to maintain its 
shape. The same volume of each formulation 
was poured onto vellum frames and allowed 
to polymerize. After each iteration, however, 
the only formulation that was able to 
consistently maintain its structure without 
tearing upon removal from the PDMS base was formulation D, which had a concentration of 4.26% 
fibrin. This formulation was also tested in a complexly shaped PDMS mold. The results are shown in 
Figure 21. This gel was able to maintain the shape of the mold from which it was removed, including 
ridges and holes. Since formulation D was the only one capable of being removed from a frame and 
manipulated, it was chosen as the formulation for further development of fibrin vascular devices. 
1cm 
Figure 21: Fibrin Gel D removed from complex mold 
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5.1.2: Sacrificial Structure Fabrication 
 As discussed in the methods section, a mold was made for the fabrication of sacrificial structures 
from laser cut acrylic. The mold, pictured inFigure 7, was reusable, and through soft lithography, dozens 
of identical PDMS based negative molds were produced, one of which is pictured Error! Reference 
source not found.Figure 8. These negative molds were in turn treated with pluronic f127, which was 
then removed, and the molds filled with 10% gelatin, which was allowed to dehydrate before removal. 
One of these single layers of gelatin can be seen in Figure 22. The PDMS negative molds and the single 
layers of gelatin could be mass 
produced to ensure a consistent supply 
of sacrificial structures. 
 
 
 
 
 
 
 
 
 
Figure 22: Single layered gelatin structure 
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5.1.3: Sacrificial Structure Lamination 
 Initial experiments with single layer sacrificial structures proved difficult, as the structure was 
buoyant and would float in the fibrin gel. If the structure was pierced and suspended with needles, it 
became extremely fragile and prone to breaking. Additionally, there is no vasculature within the body 
with similar geometries to the single layered sacrificial structures, which maintained their 1.5 mm width 
but were only approximately 0.04 mm in height. To address these issues, structures were laminated in 
four different ways to thicken the structures discussed in Section 4.1.4: Lamination Techniques. A 
representative image of the top and side of each of these lamination method follows. . The structure 
made using method A, Figure 23, did not retain its rectangular top geometry, nor did it have a flat, even, 
well bonded layers. shows the structure made using method B.  This structure maintained its top 
geometry with greater accuracy, but remained poorly bonded between layers, and showed some 
leakage of gelatin glue. Method C is pictured in Error! Reference source not found.Figure 25. This 
structure kept its  
 
Figure 23: Schematic drawing, top and side view of a sacrificial structure using lamination method A, 
stacking two hydrated gelatin layers. Arrows point to deviations from rectangular channel shape and 
delamination between layers. 
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 rectangular top geometry very well, maintaining clear straight lines. However, the layers were not 
evenly bonded, and were separating  in the side view. . Finally, we attempted method D, illustrated in 
This lamination method provided not only unchanged top geometry, but also no visible separation 
between the layers. For this reason, method D was the lamination strategy of choice for future 
experimentation.  
 
 
 
 
 
 
 
Figure 24: Schematic drawing, top and side view of a sacrificial structure laminated using method B, stacking two 
hydrated gelatin layers with a layer of fibrin glue between. Arrows point to leakage of gelatin glue and delamination 
between layers. 
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Figure 26: Schematic drawing, top and side view of a sacrificial structure made using lamination method D, one dry structure and 
one Partially rehydrated structure 
 
Figure 25:Schematic drawing, top and side views of a sacrificial structure laminated using method C, two dehydrated structures 
with a layer of gelatin glue. Arrows point to areas of delamination and leakage of gelatin glue. 
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5.1.4: Initiation of Fluid Flow 
 Once the gel formulation, sacrificial structure lamination 
technique, and the proper method of suspending a structure within a 
block of hydrogel were established, continuous perfusion was initiated by 
melting the gelatin structure, puncturing both ends of the fibrin vascular 
network, and initiating flow from a syringe pump. The QR code pictured in 
Figure 27: QR Code leading to video showing perfusion of fibrin vascular 
device leads to a video showing said flow. 
5.1.5: Sacrificial Structure Morphometric Analysis 
 Two experiments were performed for the morphometric analysis of the gelatin sacrificial 
structures. First, structures were 
photographed dry next to a scale. These 
analyses were not capable of measuring 
cross-sectional area, so a second round 
of experiments was performed on the 
dry sacrificial structures. Structures 
were snapped in half, and the cross-
section of each channel and inlet were 
photographed and measured. 
Figure 27: QR Code leading to 
video showing perfusion of fibrin 
vascular device 
Figure 28: Dimensions measured in morphometric analysis 
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The measured dimensions for the first experiment are shown as overlays on Figure 28, as well as 
in Chapter 4: Methods. Measurements were performed using ImageJ to an 𝑛 of 20. The mean values for 
each of these dimensions, as well as standard deviations, range and median, can be found in Table 4. 
Table 4: Dry Sacrificial Structure Statistics 
Dimension
Range    
(mm)
Median 
(mm)
Mean ± SD 
(mm)
Structure 
Length
13-19 15 15 ± 1.4
Structure 
Width
3.5-5.2 4.7 4.5 ± 0.52
Divider 
Width
0.73-2.4 1.7 1.6 ± 0.32
Channel 
Width
0.91-2.0 1.4 1.4 ± 0.30
 
The cross-sectional areas of the sacrificial structure channels were measured by standing them 
in a block of PDMS and imaging from the top. Figure 29 is an illustration 
of this process. A total of 21 channels (inlets or outlets) were 
photographed in this manner. A representative image of one of these 
points can be seen in Figure 30. The heights and widths were measured 
of each channel cross section.f. Average results and standard 
deviations from these measurements can be seen in Table 5. The 
median values and range were also recorded. Overall, while the top 
Figure 29: Illustration of how 
sacrificial structures were oriented 
for cross-sectional photography 
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view of the sacrificial structures saw very limited deviation across samples, the cross-sectional area 
measurements saw significant irregularity. The calculated and measured areas were very similar, but 
standard deviations for both values were over 45% of the mean. 
Table 5: Mean values and standard deviations of sacrificial structure cross-sections 
Dimension Range Median Mean ± SD
Height (mm) 0.37-1.07 0.74 0.73 ± 0.20
Width (mm) 1.19-1.57 1.75 1.33 ± 0.39
Calculated 
area (mm2)
0.434-1.67 1.63 0.99± 0.45
Measured 
Area (mm2)
0.41-1.36 1.1 0.96 ± 0.45
 
Figure 30: Representative image of a sacrificial structure inlet. 
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5.1.6: Histological Analysis of Vascular Channels 
 The final experiment for the first objective of this thesis was a histological analysis of the 
channels left behind after the sacrificial structure has been removed. Figure 31 is a representative image 
of one of these sections. Channels were then measured using ImageJ 
 Ten slides were taken from each sample (𝑛 = 7), and all sample averages were used to obtain 
the average value across all samples. Values for the average dimensions across all seven samples can be 
found in Table 6. 
Figure 31: Histological section of fibrin vascular device. 
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Table 6: Histological Analysis of Channel Dimensions 
Dimensions
Sample 1 ± 
SD
Sample 2 ± 
SD
Sample 3 ± 
SD
Sample 4 ± 
SD
Sample 5 ± 
SD
Sample 6 ± 
SD
Sample 7 ± 
SD
Mean Value 
± SD
Height             
(mm)
0.73±0.06 0.68±0.04 0.81±0.19 0.77±0.05 0.70±0.19 0.64±0.06 0.63±0.04 710.0±66.52
Width                     
(mm)
1.51±0.07 1.64±0.05 1.36±0.10 1.56±0.11 1.04±0.25 1.57±0.05 1.81±0.06 1.50±0.24
Calculated 
Area        
(mm²)
1.11 ±0.11 1.11±0.06 1.09 ±0.02 1.19 ±0.84 0.73 ±0.23 1.01 ±0.08 1.14±0.07 1.06 ±0.15
Measured 
Area        
(mm²)
0.98 ±0.19 1.07±0.16 1.22 ±0.03 1.31 ±0.11 0.75±0.22 1.06±0.10 1.30 ±0.14 1.10 ±0.20
 
This table shows that while there may be some major differences between channels, the 
standard deviations within a single sample tend to be rather low, with the largest being 31%, for the 
calculated area of sample 5. 
5.1.7: Comparison Between Sacrificial Structures and  Channels 
 A student’s t-test was performed using the average heights and widths of the channels and the 
sacrificial structure cross-sections to find if the channels made by the sacrificial structures were 
statistically different from the structures themselves. The results shown in Figure 32, both with P>0.05, 
show that there is no statistically significant difference between the size of the structure and the size of 
the produced channels. The T value of the height comparison was 0.04, and the t value for the width 
comparison was 1.32. The channels were measured at an 𝑛 of 7, while the structures were measured at 
an 𝑛 of 21.  
It was found that there was a height scaling factor of 0.36 between the measured height of the 
channels and structures when compared to 2 PDMS molds, and a width scaling factor of 0.71, meaning 
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that we can predict the shrinkage of a gelatin based sacrificial structure made using this method, and 
the size of the resulting channels. 
 
Figure 32: Student's t-test between sacrificial structure and channel height and width compared to PDMS molds. In both cases, 
P>0.05 means that there is no statistically significant difference between the structures and the channels that they create. 
5.2: Diffusive and Fluid Flow Properties of Fibrin Vascular Devices 
 This section presents the results obtained from experiments focusing on the flow and diffusive 
properties of the robust fibrin gel devices, encompassed by the second objective. Two experiments were 
run to fulfill this goal. The first was designed to observe properties of flow to compare to physiological 
values. The second was to measure the diffusion of differently sized particles through the bulk of the 
fibrin hydrogel. 
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5.2.1: Fluid Flow Properties: 
 The experiment used to establish flow properties involved the perfusion of a fibrin vascular 
device with a suspension of polystyrene microbeads in PBS. A total of 15 videos were recorded for 15 
seconds each. Ten particles from each video were identified and the distance between their starting and 
ending position measured. The starting position of each particle tracked was recorded, as in Figure 33. 
The averages of each group of ten particles was calculated. The distance traveled by all particles can be 
found in Appendix 3: Particle Tracking Measurements. The final average particle speed was found to be 
0.096 ± 0.038 mm/s. The 
standard deviation of this 
value is so large because 
in the videos, flow could 
be seen moving faster 
towards the center of the 
channels than the edges, 
meaning that the fibrin 
vascular channels 
displayed parabolic flow. 
From the average 
particle speed and other 
known values, several 
flow properties were calculated, including volumetric flow rate, the Reynolds number, and wall shear 
stress. 
Figure 33: Representative image of the starting positions of microbeads within a fibrin 
vascular channel. The chosen particles were scattered throughout the full width of the 
channel, and large enough to easily visualize. 
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5.2.1.A: Volumetric Flow Rate 
 The volumetric flow rate was calculated using Equation 1 Equation 1, found in Section 4.1.4: 
Lamination Techniques. Both the expected volumetric flow rate, based on the output of the syringe 
pump, and the measured flow rate, based on average particle velocity, were calculated. The average 
particle velocity was based on measurements as discussed in Section 4.2.1. The results are below. 
Qexpected was calculated based on the flow rate of the syringe pump. 
𝑄𝑒𝑥𝑝𝑒𝑐𝑡𝑒𝑑 =
7.5 ∗ 10−7𝑚3
ℎ𝑜𝑢𝑟
∗
1⁡ℎ𝑜𝑢𝑟
3600⁡𝑠𝑒𝑐𝑜𝑛𝑑𝑠
= 2.08 ∗ 10−10
𝑚3
𝑠𝑒𝑐𝑜𝑛𝑑
= 0.208
𝑚𝑚3
𝑠𝑒𝑐𝑜𝑛𝑑
 
𝑄𝑎𝑐𝑡𝑢𝑎𝑙 =
9.62 ∗ 10−5𝑚
𝑠𝑒𝑐𝑜𝑛𝑑
∗ 2.12 ∗ 10−6𝑚2 = 2.04 × 10−10
𝑚3
𝑠𝑒𝑐𝑜𝑛𝑑
= 0.204
𝑚𝑚3
𝑠𝑒𝑐𝑜𝑛𝑑
 
The actual volumetric flow rate was calculated to be nearly identical to the predicted value once both 
fluidic channels within the fibrin vascular device were considered. Slight differences can be attributed to 
relying on average channel geometries to calculate the flow rate, rather than the actual channel 
geometries for each video recorded. 
5.2.1.B: Parabolic Flow and Reynolds Number 
Reynolds number determines if flow is considered laminar, transitional, or turbulent. Equation 2 
(Section 4.4.1: Microbead Flow Analysis), requires values for the density of the liquid (in this case PBS), 
the velocity of the fluid flow, the length of the channel, and the viscosity of the liquid.  The density of 
PBS is 1000 kg/m3 and the viscosity is 1 N*s/m2. One Newton is equal to one kg*m/s2. Substituting this 
value allows for all units to cancel out, as Reynolds number is a dimensionless value.  
The Reynolds number calculation is below. 
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𝑅𝑒 =
1000
𝑘𝑔
𝑚2
⁄ ∗ 9.62 × 10−5
𝑚
𝑠 ∗ 0.012𝑚
1.0
𝑁𝑠
𝑚2
= 1.15 × 10−3 
𝑅𝑒 =
1000
𝑘𝑔
𝑚2
⁄ ∗ 9.62 × 10−5
𝑚
𝑠 ∗ 0.012𝑚
1.0
𝑘𝑔 ∗ 𝑚 ∗ 𝑠
𝑚2 ∗ 𝑠2
= 1.15 × 10−3 
This Reynolds number value is well under 2300, meaning the flow created within the fibrin vascular 
device is laminar. 
 Flow within a laminar system is also parabolic in nature, meaning that flow towards the center 
of the channel is faster than towards the edges. We confirmed that our flow matched this profile by 
measuring the velocity of particles within regions of the fibrin vascular devices. Figure 34and Table 7 
show the mean and standard deviation of particle velocity passing through the channels. The standard 
deviations of these values are quite high due to differences between channels. Figure 34shows that 
there is a parabolic fit between channels. 
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Table 7: Average Flow Velocities across Channel Regions 
 Average Flow Velocity (mm/s) 
Region 1 0.08±0.01 
Region 2 0.09±0.03 
Region 3 0.10±0.04 
 
Figure 34: Parabolic Flow within Fibrin Vascular Devices 
 
5.2.1.C: Wall Shear Stress 
To calculate wall shear stress, an additional calculation had to be run. The shear force equation 
requires maximum speed, and what was calculated from the particle flow study was the average speed. 
Due to the nature of flow within channels, the maximum particle speed will come at the center of the 
channel. This is calculated from Equation 7 Equation 7 (Section 4.4.1: Microbead Flow Analysis). This 
value is below. 
𝑢𝑐𝑒𝑛𝑡𝑒𝑟 =
3
2
(9.62 ∗ 10−5)
𝑚
𝑠𝑒𝑐𝑜𝑛𝑑
= 1.44 × 10−4
𝑚
𝑠𝑒𝑐𝑜𝑛𝑑
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With this maximum speed value and Equation 4 Equation 4, the wall shear stress was calculated where τ 
represents wall shear stress: 
𝜏 =
−8 [1 ∗ (1.44 × 10−4
𝑚
𝑠𝑒𝑐𝑜𝑛𝑑) ∗ (7.49 × 10
−4𝑚)]
(1.50 × 10−3𝑚)2
= −0.385
𝑁
𝑚2
 
5.2.1.D: Non-Uniform branching of fluid flow While all values calculated above are based on average 
values obtained over the analysis of 150 individual particles from 15 videos. These videos were taken 
from a total of five different channels within three different devices. The consistency of fluid flow 
between channels is an important consideration for this work. If channels are perfectly bifurcated and 
channels are identical, fluid velocity and volumetric flow rate should be identical across all channels. 
Unfortunately, as outlined in Table 8, this does not appear to be the case. While this discrepancy exists, 
it is most likely the result of regional Non-uniformities in the channels, and slight differences in channel 
size.  
Table 8: Individual Channel Velocities and Volumetric Flow Rates 
Channel 
Average Velocity 
(mm/s) 
Channel Area 
(mm2) 
Volumetric Flow Rate 
(
𝑚𝑚3
𝑠
) 
Experiment 1 Channel 
1 
0.08±0.02 0.88 0.09 
Experiment 2 Channel 
1 
0.05±0.01 1.20 0.07 
Experiment 2 Channel 
2 
0.12±0.05 1.46 0.17 
Experiment 3 Channel 
1 
0.10±0.01 1.28 0.12 
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Experiment 3 Channel 
2 
0.13±0.02 1.81 0.24 
 
5.2.2: Diffusive Properties of Fibrin Vascular Devices 
 An experiment was run to measure the diffusive properties of fibrin vascular devices. In this 
experiment, FITC-dextran was perfused through the channels. Two different sizes of dextran were used 
for this experiment to observe how differently sized particles diffuse through the fibrin gel. The 
molecular weights used were 40 kDa and 250 kDa. 
 Time lapse videos were recorded, and three lines that stretched through the channel and 0.5 
mm on either side were selected along the length of the channel for analysis d. The intensity profile was 
taken along the lines for each frame of the video. Figure 35 shows the change in intensity profile from 
Figure 35: Intensity profiles of a microfluidic channel in the first (left) and last (right) frames of a 15 minute 
long time lapse video diffusing 40 kDa FITC Dextran. Red lines represent channel edges. Channels are 
fluorescing white as dextran diffuses into the black area of the fibrin device. The graphs show diffusion 
spreading and increasing in intensity. 
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the first to the last frame of an 18-minute-long time lapse video. The specific pixel values were taken 
from the List function at the bottom of the intensity plots and put into a Microsoft Excel sheet. These 
values were then plotted per time point. If a plateau occurred at any point on a graph, this meant that 
the video had become saturated, and data from that region of interest would not be usable, as the 
maximum recorded intensity may not be representative of the actual level of diffusion. Figure 36  below 
shows one of these graphs with a visible plateau, circled, unlike Figure 37. On Figure 37, each 
consecutive timepoint is plotted in a lighter shade of green. As more time elapsed in this diffusion, the 
intensity increased both in maximum value, but in spread as well. 
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  From the recorded fluorescent intensities, we graphed intensity ratios against the channel 
average at each time point at several distances from the channel edge. As time passed, represented by 
Figure 36: Graph of a diffusion video with an area of saturation (circled) 
Figure 37: Graph of a region of interest from the same diffusion video as the previous figure. There are no visible plateaus in this 
image. 
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the darkening line, the fluorescent intensity at each point increased, while remaining highest at the 
channel edge (Figure 38). 
  
The diffusivity of that region was calculated using Equation 8. The mean and standard deviation for 
these values for each size of FITC-dextran can be found in Table 9.  
Table 9: Diffusivity of 40 kDa FITC Dextran and 250 kDa FITC Dextran 
Diffusivity Mean ± SD (mm2/s) 
Distance from Channel Edge 
(mm) 
40 kDa FITC Dextran 250 kDa FITC Dextran 
0.1 1.00 ± 0.67 ×10-5 5.72 ± 5.17 ×10-6 
0.2 2.47 ± 2.30 ×10-5 1.71 ± 1.98 ×10-5 
0.3 4.31 ± 4.67 ×10-5 3.55 ± 4.88 ×10-5 
T =0 seconds T =1050 seconds 
Figure 38: Intensity curves for 40 kDa and 250 kDa dextran at various distances from channel edge 
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0.4 6.34 ± 7.99 ×10-5 5.64 ± 8.07 ×10-5 
0.5 9.31 ± 12.72 ×10-5 8.36 ± 11.74 ×10-5 
Mean 4.69 ± 3.27 ×10-5 3.96 ± 4.56 ×10-5 
 
Values in this table show some standard deviations that are larger than their means. While not 
ideal, this is because the means are recorded across all 35 time points (every 30 seconds for 18 
minutes). A full table of average diffusivities can be found in Appendix 4: Mean Diffusivity 
Measurements. There is also a trend of higher diffusivity at the points further away from the channel 
edge. 
 
5.3: Cellular Uptake of Fibrin Vascular Devices 
 This section presents the results acquired from the experiment designed to fulfil the third 
objective of this project: determining zones of cellular uptake. As mentioned in Chapter 4, this was done 
by perfusing a fibrin vascular device with calcein AM dye loaded, serum-free media for a total of four 
hours with images taken at one and four hours. The images were then normalized and the area in which 
calcein AM was taken up by cells was outlined and measured to determine the cellular uptake area of 
Figure 39: Calcein AM uptake study at t=1h (left) and t=4h (right). Yellow lines show the outline of dye uptake region. 
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the calcein AM dye. Visualization of these regions can be seen in Figure 39. The measurements taken 
from these studies can be seen in Table 10 below. In both the change in area and the average uptake 
distance from the channel edge, the values approximately doubled between the 1 hour and 4 hour time 
points. Calcein AM was chosen for this set of experiments because it only becomes fluorescent when 
cleaved by intracellular esterases, meaning it must pass through a live cell membrane to fluoresce. Thus, 
all of the visible cells in Figure 39 are still alive after the elapsed time. 
Table 10: Average uptake area and diffusion plane of calcein AM dye (𝑛 = 3) 
Time 
(hours)
Average Uptake 
Area (mm²)
Average Change in 
Area (mm²)
Average Distance 
of Cellular 
Uptake (mm)
Average Change in 
Cellular Uptake 
Distance(mm)
1 0.79 ± 0.27 0.26 ± 0.09
4 1.51 ± 0.35 0.50 ± 0.12
0.72±0.11 0.24 ± 0.04
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Chapter 6: Discussion 
 The long-term goal of this project was to develop a monolayered fibrin based vascular network 
for use in in vivo vascular repair, vascularization of full thickness tissue engineered constructs, as well as 
a possible in vitro platform for drug testing and vascular modeling. Currently, when vasculature is 
damaged or diseased in vivo, there are limited options for treatment. Depending on the disease or 
damage type, it is sometimes possible to treat macrovasculature such as veins and arteries with stents 
or vascular autografts from a patient’s own saphenous vein [5]. In the case of microvasculature, the 
most common treatment is pedicle flaps [16], [17], [18]. While these methods have seen some 
considerable success, they both see problems with morbidity, both at donor site and implant site, 
shifting and degradation over time, and limited availability of donor material [5], [16], [17]. Tissue 
engineered constructs are currently limited to skin and cartilage, as these are some of the only tissues 
capable of surviving more than 200µm away from vasculature [1]. These limits persist because, while 
considerable work has been done towards this goal, there has yet to be a suitable substitute for 
vasculature which can provide a platform for full thickness tissue engineering [19, 20]. Current in vitro 
vascular models have been extremely successful in creating various organ environments, but the gold 
standard, PDMS, has proven a poor matrix for cell attachment and signal incorporation, and often saw 
leakage from within fluidic channels [2], [6, 24]. Towards this goal of creating a versatile platform with 
the capability to be developed to address any and all of these limitations of vascular engineering, a 
monolayered fibrin based vascular device was developed, characterized for its channel reliability, its 
flow and diffusive properties, and its ability to maintain a cell population on the surface. 
 In this study, a seamless fibrin vascular network was created using gelatin as a sacrificial layer to 
eliminate the need for layering hydrogels, which is a common cause for the leakage seen in hydrogel 
derived fluidic systems. The system was designed in two major parts: a fibrin gel capable of maintaining 
a stable network of channels and sacrificial structures capable of reliably exhibiting physiologically 
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relevant dimensions and producing channels of predictable size. Photographs were taken of sacrificial 
structures to measure both the 2D and cross-sectional dimensions of the produced sacrificial structures 
and compared to measurements taken from histological sections of a perfused fibrin device. 
6.1: Development of a Reliable Fibrin Based Vascular Network 
6.1.1: Manufacture of fibrin vascular devices 
 This section consisted of a series of trials for choosing the proper materials and proper 
fabrication methodology for making a fibrin based vascular device. For the first several experiments, 
namely the testing of various formulations of fibrin gel and the fabrication and lamination of sacrificial 
structures, the results were nearly entirely qualitative. Fibrin gels were assessed based on their ability to 
be lifted from a surface and manipulated. This is because in the use of these fluidic devices, they are at 
least briefly handled in order to access the edges for piercing and perfusion and need to maintain an 
enclosed channel without collapse. Forming channels within lower concentration fibrin gels had been 
problematic in previous iterations of this work, with channels frequently leaking or collapsing within the 
gel [35]. When the first attempts at fibrin gel, formulation A, failed to maintain their integrity when 
simply lifted from a cured PDMS surface before a sacrificial structure was involved, it confirmed that this 
gel would not function satisfactorily, and the other gel formulations were attempted. Knowing that 
increases in concentrations and volumes of both fibrinogen and thrombin could be used to change the 
mechanical properties of fibrin gels gave a direction for future attempts [33]. In the end, only 
formulation D could be consistently lifted from the surface of treated PDMS without tearing and 
remained intact when handled. This made it the best choice for use in the fibrin vascular devices. The 
material and channel were more structurally sound, and throughout the course of this project, there 
was no case of channel collapse. It was still possible for leaks to form when gelatin structures rose to the 
surface of the device during polymerization, another problem detailed in previous iterations, but during 
the completion of this thesis, these were fairly rare [35]. This increased structural integrity was due to 
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the higher concentrations of both fibrinogen and thrombin increasing the fiber length within the gel[33]. 
The fact that we were able to develop a fibrin gel that was capable of maintaining structural integrity as 
well as being capable of movement and manipulation will allow for more complex scaffold builds and 
experiments in the future.  
 The lamination of sacrificial layers was also a qualitative set of experiments directed towards 
finding the best possible method for structure production. In order to produce channels which are 
completely open without risk of fibrin infiltration which could disrupt flow, it is necessary to have well 
bonded layers without gaps or bubbles. For the structure to be considered reliable and reproduceable, it 
is also essential for it to maintain the intended shape and dimensions as designed for with the 
SOLIDWORKS model and PDMS negatives. Of the methods attempted, it was found that structures that 
had been allowed to completely dehydrate within the PDMS mold were the best at keeping their shape. 
The two methods involving dry structures also bonded the best, but gelatin glue tended to not always 
make full contact across the entire monolayers during bonding, which caused some separation between 
layers, leaving the partially rehydrated as the best option, both in full bonding and in the retention of 
shape. It was the method used going forward from this point. 
6.1.2: Morphometric Analysis of Sacrificial Structures and Histological Analysis of Fibrin Fluidic 
Channels 
 One of the most important goals of this project was to have the channels within the fibrin 
devices mimic physiological values for vasculature. Past iterations of this project had seen considerable 
difficulty in producing microscale vascular channels, so for the sake of this thesis, the intention was to 
scale the channels up to a larger, but still physiologically relevant channel size [6]. The range of 
physiologically relevant values was taken from textbooks by Berger and Frietas, and can be found in 
Table 11[8, 9]. 
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Table 11: Physiological Values for Vascular Size and Flow Rate 
Vasculature
Diameter 
(mm)
Mean Flow Rates 
(mm3/s)
Large Arteries 2.0-6.0 1600-5700
Small Arteries 0.3 3.5
Arterioles 0.01-0.14 0.025  
The morphometric analysis was performed both by photographing the 2D top surface of the 
sacrificial structures and by photographing the cross-sections using a stereoscope and measuring all 
dimensions in ImageJ. These were then compared to channels made within a fibrin vascular device. 
Results from this set of experiments showed that we were successful in creating channels and sacrificial 
structures that mimicked the size of small arteries. While this cannot be considered microvasculature, 
the experiments succeeded in creating a bifurcated perfusable network of physiological relevance within 
a block of fibrin hydrogel. 
Another important finding from this set of experiments was that there is no statistical difference 
between gelatin sacrificial structures and the fluidic channels they create within a block of fibrin gel. We 
were also able to calculate a scaling factor for this particular method of channel fabrication based on the 
differences between expected and experimental geometries. This means that, despite the fact that 
these channels are not currently considered microvascular, the same method used in this thesis could 
apply to later iterations of this project directed towards scaling down channel size and increasing 
complexity. Because we also know by what percentage structures shrink while being developed, we 
have a better understanding of how molds should be fabricated in order to achieve desired dimensions. 
This greater understanding will be vital for when this method is further developed towards 
microvasculature rather than the meso-vasculature modeled in this thesis.  
Gelatin has been used as a sacrificial structure multiple times in the creation of hydrogel based 
fluidic devices, so while it was expected, the fact that it has been experimentally shown that this method 
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works in a robust fibrin gel fluidic network means that a gelatin based sacrificial structure method is 
reliable and a viable option for future development [24, 29, 30]. 
6.2: Assessing Flow and Diffusive Properties of Fibrin Vascular Devices 
6.2.1: Flow Properties of Fibrin Vascular Devices 
 The flow properties of the fibrin vascular channels were calculated based on a series of 
perfusion experiments using 6µm polystyrene beads. These beads were chosen to mimic the size of 
neutrophils in the vascular system and were recorded in time lapse videos at 6 frames per second. 
Particles were tracked over the course of these 15-second-long videos to find an average speed, which 
was then used to calculate volumetric flow rate, Reynolds number, and wall shear stress.  
 While volumetric flow rate is an important property of fluid flow, it is determined primarily by 
the syringe pump’s settings. The point of these calculations was not to test the viability of the syringe 
pump. The pump was set to perfuse at a rate of 0.21 mm3/s, which is a physiologically relevant rate for 
small arteries(Table 11). Instead, this experiment was intended to prove that flow through the channels 
could match expected flow properties based on conservation of flow from the tubing into the channels 
themselves. The measured value is nearly identical to the calculated expected value, with a margin of 
approximately 0.004 mm3/s. There are a few possible reasons for this very slight difference. First, the 
expected value based on conservation of flow calculations relies on an average channel size in 
calculations. Additionally, because particles to track were chosen for their size and visibility, it is possible 
that the average particle speed is slightly skewed. Overall, however, the results showed values similar to 
what was expected of the system, meaning that it abided by conservation of flow. Reynolds 
number was calculated to observe the turbulence of flow. In the body, flow is almost exclusively 
laminar, meaning that it has a Reynolds number below 2300. Because this project is intended to develop 
a vascular model, it is ideal to mimic the linear flow of blood vessels. The calculated Reynolds number 
for this experiment was 1.15×10-3, which is a strongly laminar value. Turbulent flow within blood vessels 
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is seen only at branching points in large arteries, the ascending aorta, diseased vasculature, and in 
aneurisms [38].  The fact that we were able to achieve such a low Reynolds number indicates that our 
flow is similar to that within small and healthy vasculature. This is important because this vascular model 
should be as similar to native tissue as possible. If this model showed turbulent flow, rather than 
laminar, it would not be ideal for use in full thickness tissue engineered models, or in in vitro vascular 
modeling. Any results seen from diffusion or flow property experiments would be skewed by the 
unsteady flow.  
All flow that is laminar is also parabolic. We were able to model this flow within our system, 
which contributes to the viability of this system. We did see, however, very large standard deviations 
within these values. These large standard deviations are most likely due to the overall difference in 
particle velocity seen due to uneven channel sizes throughout the study. These high standard deviations 
are not ideal, and do further emphasize that the non-uniform branching is a limitation to this system. 
 Finally, wall shear stress was calculated from this experiment. Wall shear stress is important 
because it plays a role in the structure and function of endothelial cells within vasculature [10]. Among 
these functions impacted by shear stress are the binding of transcription factors by shear stress 
responsive promoter elements [10]. While the physiological average shear stress within vasculature 
ranges between 1 and 4 N/m2 in most arteries, areas of bifurcation often see stress dropping to as low 
as 0, or even negative values at branching points in blood vessels [10]. Thus, not only was the measured 
experimental value of 0.385 N/m2 physiologically relevant, it was both well below the maximum value, 
and above the minimum value. This makes a promising argument that future experiments aimed at 
endothelializing the fibrin channels will see fully functioning endothelial cells. The wall shear stress value 
we calculated was below the average in vasculature, but it was also taken within a few millimeters of a 
branching point, where wall shear stress is expected to be lower. This means that our model system 
shows even further similarity to values within native vasculature.  
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 One limitation of these fibrin vascular structures does, however, have to do with flow and flow 
rates. We found that between channels, even channels within the same device, the average speed of 
flow and thus the volumetric flow rate was not identical. This is likely due to the fact that the channel 
width of each channel changed slightly between each devices and structures (Table 8). As expected 
based on Equation 1, there was a greater flow rate within channels of larger areas. Despite the 
differences between structures, we remained successful in maintaining flow rates consistent with small 
arteries.  
Further work will need to be done in order to improve bifurcation in order to make flow rate constant 
across the entire system. 
 Overall, the calculated flow properties of the fibrin vascular network have proven that flow is 
conserved and reliable within channels, flow is laminar, like in blood vessels, and the shear stress 
applied to the walls of the channel by fluid flow is within physiological norms. While we do see a 
limitation in non-uniform bifurcation, the overall flow within the fibrin vascular device meets the goal of 
being physiologically relevant. 
6.2.2: Intensity Curves and Diffusivity of Fibrin Vascular Devices 
 The intensity curves seen in Figure 38 are a clear visualization of the diffusion of the FITC 
dextran. As expected, the fluorescence intensity is highest at the channel edge and dissipates quickly 
upon its diffusion into the fibrin hydrogel matrix. As time passes, and more dextran becomes diffused, 
the intensity curves increase, while maintaining the exact same shape. This means that our diffusivity is, 
while not consistent, predictable.  
 As mentioned in the results section and shown in Table 9, we see very high standard 
deviations within our system. This is because diffusivity is not consistent over time and distance. The 
averages seen in the table below are the averages not only over an 18 minute period, but also at five 
different points away from the channel edge. This led to a system average over a wide range of 
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conditions. The diffusivity tends to increase the further the measurement was taken from the channel 
edge. This is not necessarily an unexpected result. In Figure 38, the intensity ratio is lower, and Equation 
8 shows that the diffusivity values and concentration ratios are inversely proportional. At lower 
concentrations of dextran, the chains entangle with each other less, allowing faster and easier diffusion 
down the gradient [39]. 
Diffusive properties are impacted by a variety of factors, including the size and shape of the 
molecule being diffused, and the concentration of the diffusive matrix. Fibrin changes properties such as 
stiffness, viscosity, and porosity with the concentration of fibrinogen and thrombin within the gel [33]. 
This means that, because a robust fibrin gel with a high concentration of fibrinogen and thrombin was 
used in this experiment, diffusivity values were observed to be very different from most published 
literature, which tends to focus on low concentration gels. Table 12 shows a comparison of our 
experimental values with literature values.   
Table 12: Experimental values compared to literature value for diffusivity within fibrin gel. Experimental values highlighted in 
grey. 
Dextran/molecule and size Fibrin Gel Diffusivity (mm2/s) 
3 kDa ~3.5% fibrin gel 2.60 ± 0.86×10-4   [20] 
10 kDa ~3.5% fibrin gel 1.15 ± 0.15×10-4  [20] 
40 kDa 0.40% fibrin gel ~4.00×10-4 [18] 
40 kDa Dextran 
4.26% fibrin gel (42.6 
mg/mL fibrinogen) 
4.69 ± 3.27 ×10-5 
70 kDa ~3.5% fibrin gel 0.99 ± 0.19×10-4  [20] 
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Diffusion within a physiological system is important because it is the method by which nutrients 
reach cells. The goal of this experiment was to establish the rate by which that happens within our 
system, and to compare the diffusion of differently sized macromolecules. As expected, our 
experimental values for 40 kDa dextran, highlighted in grey in Error! Reference source not found.Table 
12, are higher than our experimental values for 250 kDa. This is a trend that can be seen throughout the 
table, specifically from Catalano et al., . which observed diffusion of four sizes of fluorescent dextran 
through a fibrin based wound sealant. Each successively larger molecular weight of dextran showed a 
lower rate of diffusivity. [20] 
 The lower diffusion rate of our experimental values may be contributed to the higher 
concentration of fibrin gel used. However, not only were diffusivity values within an order of magnitude 
of other published data for dextran in fibrin gel, but our diffusivity also falls within an order of 
magnitude of diffusivity into native tissue. Reissis et al. diffused 40 kDa dextran into articular cartilage,  
and found a diffusivity of 5.8±1.0×10-5 mm2/s [18]. While 5.8±1.0×10-5 mm2/s and 4.69 ± 3.27 ×10-5 mm2/s 
are different from each other, we managed to create a vessel with diffusivity within the same order of 
magnitude as into native tissue.  
 Our diffusivity values also remained within reasonable range for particles diffusing out of native 
vasculature. Table 13 details the diffusion of small particles out of vasculature. We do, again, see 
differences on the scale of an order of magnitude, but the particles being diffused out of vascular tissue 
are much smaller than those being diffused out of the fibrin vascular devices. In the grand scheme, 
250 kDa Dextran 
4.26% fibrin gel (42.6 
mg/mL fibrinogen) 
3.96 ± 4.56 ×10-5 
500 kDa ~3.5% fibrin gel 0.34 ± 0.07×10-4     [20] 
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further testing should be done, but we were able to acquire vascular diffusion rates similar to what was 
seen out of native tissue.  
Table 13: Fibrin vascular device diffusivity compared to native vascular tissue. Experimental values highlighted in grey. 
Particle 
Molecular Weight 
(kDa) 
Matrix Diffusivity (mm2/s) 
H₂O 0.02 Arterial Wall 0.79±0.04×10-3 [40] 
Glucose 0.18 Aorta 1.43±0.24×10-4 [41] 
FITC Dextran 40 Fibrin Vascular Device 4.69 ± 3.27 ×10-5 
FITC Dextran 250 Fibrin Vascular Device 3.96 ± 4.56 ×10-5 
 
 It is clear that the diffusive properties seen from our experiments did not exactly match those of 
published literature or native tissue. While our values remained within the range of an order of 
magnitude, a large difference in diffusivity is not ideal for a vascular model. As discussed above, the 
porosity of fibrin gel can be adjusted by changing concentrations of fibrinogen and thrombin, which 
would change the overall diffusivity [33]. Further testing of fibrin gel formulations may produce a gel 
with diffusive properties more similar to those of native tissue. 
 
6.3: Cellular Uptake on Surface of Fibrin Vascular Devices 
 In order to achieve the long-term goal of the fibrin vascular devices being utilized in the 
vascularization of full thickness tissue engineered constructs or in tissue repair, it is imperative that the 
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robust fibrin gel is capable of providing nutrients and oxygen to cells found on the surface of the 
network. The experiments run to establish cellular uptake showed that not only were cells capable of 
taking up nutrients, in this case media loaded with dye, but the uptake zone increased over time. The 
visualization of live cells on the surface of these fibrin vascular constructs is promising for future 
development of these structures. 
 After the one-hour point however, the uptake by cells seemed to have slowed This is because 
the diffusion of the calcein AM would not have scaled  linearly over time [42].  Visible uptake area could 
also have been effected if the cells that took up the dye were either dim or not in focus, and thus 
washed out by the normalization. The normalization itself may have cause further irregularities within 
the data obtained from these experiments. In the representative image, the area of cellular uptake 
appears to be rounded in nature. Given that the calcein loaded media was being flowed through the 
channels constantly at an even rate, the diffusion distance should have appeared linear. In Figure 39, 
one will notice that fluorescence is brightest along the channel edge, and there was a particularly bright 
area directly behind the furthest reach of the uptake area. It is possible that during normalization of 
these images that the brightness along the channel edges caused other cells that had taken up the 
calcein dye to be removed by the normalization.  
Chapter 7: Future Work and Recommendations 
 This thesis focused on the fabrication of a monolayered fibrin vascular device that would be able 
to mimic physiological properties of flow and diffusion for the purpose of sustaining a cell population. 
The developed devices have been shown to be capable of reliable perfusion as well as being able to 
supply cells on the surface with media. These are promising results which lend themselves to further 
development in the future, for possible use in vascularizing full thickness cardiac patches and an in vitro 
vascular model for drug screening. For either of these to occur, further testing is needed to gain a better 
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understanding of this system, and to increase the physiological relevance of the encased vascular 
network. 
7.1: Short Term Recommendations 
 There are several short-term recommendations which specifically target the fabrication of more 
complex networks, as well as the endothelialization of the inner channels. These short-term 
recommendations focus on making a more accurate model of a vascular network within a block of fibrin 
gel using our established methodology. 
7.1.1: Increasing Network Complexity 
 While the two-channel network that has been established has shown good results, it was 
established in its current form for proof of concept studies. In order to make a true vascular network, it 
is necessary to build a larger, high complexity network of channels. This brings with it its own array of 
complications, such as pressure within channels, mold fabrication, and channel size. 
 As shown by COMSOL modeling by Borenstein et al., the best way to manage pressure drop 
across channels of decreasing size is to follow the principals of Murray’s Law [6]. Murray’s law, shown in 
Equation 9, states that the cubed width of the parent channel should equal the sum of all daughter 
channels cubed. Due to the maintenance of pressure across branched channels, future iterations of this 
project with more complex networks should be modeled according to this principal. 
Equation 9: Generalized Murray's Law 
𝑊𝑃𝑎𝑟𝑒𝑛𝑡
3 =∑𝑊𝐷𝑎𝑢𝑔ℎ𝑡𝑒𝑟𝑠
3  (9) 
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 The mold used in this thesis for the fabrication of sacrificial structures was laser cut from acrylic 
and was assembled out of multiple pieces. While this worked for this application, it did have some 
problems: slight damage, leakage, unknown additional height added due to the presence of adhesive 
layers, and difficulty to reproduce and replace. To address these concerns, I experimented with the use 
of thermoplastic shrinking polystyrene sheets, or “Shrinky-Dinks”. These thermoplastic shrinking 
polystyrene sheets have been experimented with in several microfluidic applications, including 3D-chips, 
fluid flow containing Chinese Hamster Ovary cells, a simple immunoassay, and the fabrication of master 
molds for soft lithography [43-46]. Etching onto Shrinky-Dinks with a craft cutter obtained channels as 
small as 65µm in width [44]. These sheets  however, often exhibit varying shrinkage tolerances from 
sheet to sheet [43]. In our own testing, done by cutting 
20x20mm squares with 10x10mm windows with a Silhouette 
Cameo craft cutter, the average shrinkage between trials was 
found to be within an average of a 2% tolerance of each other. 
This data can be found in Appendix 5: Shrinky-Dink Analysis. 
 Preliminary sacrificial structure manufacturing was performed with the use of Shrinky Dink 
based master molds. Shrinky Dinks were cut using the Silhouette Cameo printer, soaked in pluronic f127, 
then covered in PDMS shown in Figure 40 to the left. The PDMS was 
then also treated with pluronic f127, and filled with 10% gelatin, shown 
in Figure 41 to the right. While the molding of the gelatin was successful, 
it was found that these gelatin layers were very difficult to work with 
and were not able to be laminated the same way as the sacrificial 
structures used in experiments. The additional channels tended to stick 
together and become entangled when rehydrated, and became difficult to untangle without damaging 
Figure 40: A Shrinky-Dink master mold (right) and 
PDMS negative (left) 
Figure 41: Gelatin structures made with 
Shrinky-Dink derived mold 
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the structure. That being said, the use of thermoplastic polystyrene sheets has proven promising for the 
future development of molds for sacrificial structures. 
 Finally, in these proof of concept studies, the gelatin structures made were large, and required a 
large volume of fibrin gel to encapsulate them. This is both wasteful, and not physiologically relevant. In 
order to create more complex networks, I suggest reducing channel size considerably to mimic smaller 
physiological structures. 
7.1.2: Reducing Channel Size 
 In order to more closely mimic physiological vascular tissue, I suggest choosing a method to 
reduce the channel size. The current channel area of the fibrin vascular devices places them 
physiologically most similar to small arteries [8, 9]. To obtain a perfusion area more relevant to the 
fabrication of full thickness tissue engineered scaffolds, it is ideal to have a larger network of smaller 
channels. The target area should be a maximum of 0.015mm2  to match the area of arterioles [8, 9]. If 
the silhouette cameo printer is not capable of cutting Shrinky-Dinks of the appropriate size to make 
PDMS negatives, I propose cutting channels directly into Shrinky-Dinks, treating the surface with 
pluronic f127, and pouring gelatin directly into the channels on the polystyrene sheets. 
7.1.3: Endothelialization of Channels 
 The results show that the fibrin vascular device is a viable model for vasculature, and is capable 
of maintaining a surface population of cells. In order to make a more accurate model for vasculature, 
however, it is essential to endothelialize the inner channels. Endothelial cells have been grown on fibrin 
before, as well as within PDMS microfluidic channels, so I propose combining some of these methods to 
hopefully obtain a confluent layer of endothelial cells. Researchers at the University of Zurich increased 
endothelial cell growth on fibrin gel by altering VEGF to be capable of binding to fibrin gel, and 
incorporating it into fibrin gel in varying concentrations [47]. In order to culture endothelial cells within 
the channels, I suggest following the method developed at Emory School of Medicine by the Lam 
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group[48]. PDMS channels were endothelialized by perfusing a 1 million cell/mL suspension of HUVECS 
in an endothelial growth media containing added dextran through microchannels for two hours at a low 
flow rate within an incubator environment (37°C and 5% CO2). At this point, the cell suspension flow was 
stopped and replaced with a perfusion of the same growth media for between two and eight days to 
achieve a monolayer of endothelial cells [48]. I believe that a combination of these two methods will 
allow for complete endothelialization of the microfluidic channels. 
 Histological analysis should be performed to ensure complete confluence of endothelial cells 
within the microfluidic channels. Having fully endothelialized channels will make the fibrin vascular 
devices better endothelial models. However, it will also change the diffusive properties, possibly by as 
much as an order of magnitude [49]. This means that once a method has been fully established for 
creating the endothelial layer, diffusion and cellular uptake experiments should be repeated. 
7.2: Long Term Recommendations 
 Once the work to develop a more complexly branched and endothelialized fibrin microvascular 
device is done, characterization should be run to assess how useful these devices will be in vivo and in in 
vitro drug testing analysis. For this, we should characterize in vitro degradation, in vivo degradation and 
biocompatibility, and finally attempt use of the fibrin microvascular device as a platform for drug 
testing. 
7.2.1: Quantify Degradation In Vitro 
 Early stent studies showed that the average time required to fully endothelialize an implant in 
vivo is 28 days [50]. While this was measured on an untreated stent, and the endothelialization time of 
fibrin is much shorter, with Wong et al. running experiments on fibrin constructs after only nine days 
[51]. With that said, fibrin based implants in vivo have been found to be completely degraded by 21 days 
[52]. It is important to determine the speed of degradation of the fibrin microvascular devices to 
determine if they would be capable of survival until endothelialization is complete. The addition of 
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aprotinin in different concentrations can adjust the degradation rate of the fibrin microvascular devices 
to ensure device survival [32]. With this in mind, future researchers should quantify the degradation of 
the fibrin microvascular devices to ensure success. I suggest this be done through the use of an ELISA 
targeting fibrin degradation products, as was used in studies by Coffin and Gaudette [53]. 
7.2.2: In Vivo Biocompatibility and Degradation 
 As mentioned above, Kidd et al. have found that a fibrin based implant had fully degraded by 21 
days [52]. The fibrin vascular devices from this thesis are made of a more robust fibrin gel than the 
implants used in that study, so experiments measuring the degradation rate of it in vivo, as well as the 
biocompatibility in vivo, should be run to establish a baseline. I suggest the use of a mouse model, as 
used by Page et al. in their fibrin microthread in vivo skeletal muscle regeneration study [54]. In order to 
line up with relevant endothelialization time and degradation estimates, I suggest time points of 8 days, 
12 days, 16 days, 20 days, and 24 days. Samples should be histologically analyzed for endothelization, 
fibrous encapsulation, and scaffold degradation. 
7.2.3: In Vitro Drug Testing Assay 
 Common uses of vascular microfluidics, as discussed in Chapter 2: Background, are the modeling 
vascular disease and the testing of pharmaceuticals in vitro, before moving to an in vivo model. I suggest 
a set of future experiments where the effects of a drug can be tested on cells on the surface of the fibrin 
vascular device. An ideal system to test would be intravenously delivered chemotherapy drugs, such as 
Doxorubicin, to a culture of tumor cells on the surface of the device, such as MOLT-4 leukemia cells, 
MCF7 breast cancer cells, or NCI-H522 small cell lung cancer cells, all of which are cancer types that 
Doxorubicin is used to treat. The fibrin vascular device can be recorded, and the cellular reaction can be 
measured in real time. If results of this experiment line up with expected cell behavior, then the fibrin 
vascular device can be established as a drug testing platform for the development of new intravenously 
delivered drugs. 
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7.3: Fabrication of a Fibrin Based Modulated Cardiac Patch 
 The thesis work of Megan Chrobak focused on the development of a modulated fibrin 
composite patch for cardiac regeneration [55]. This body of work was successful in developing a 
biomimetic cardiac patch capable of 
aligned contraction and shows promise 
as a functional ventricular wall 
replacement. Like most tissue 
engineered constructs, however, it is 
limited by thickness and the diffusion 
limit of oxygen [55]. In order to 
function as a full thickness tissue 
engineered construct, a vascular network needs to be put in place. The fibrin vascular devices may be a 
good solution to this problem. 
Preliminary testing was performed with layering one of these cardiac patches seeded with rat neonatal 
ventricular monocytes on the surface of a fibrin vascular device (Figure 42). The fibrin vascular device 
was perfused with a 2µL calcein AM loaded dPBS solution for 75 minutes to observe diffusion of dye to 
the surface. As previously mentioned, calcein AM becomes fluorescent only once hydrolyzed by 
intracellular esterases [55]. After this perfusion, images were taken at 40X on an upright fluorescent 
microscope. From these images, shown in Figure 43 below, it was clear to see that the calcein reached 
the cells within the cardiac patch, and the fibrin microthreads within the composite batch were clearly 
identifiable. While much work remains to be done to perfect the integration of cardiac composite 
patches with fibrin vascular devices, initial results show promise for the development of a full thickness, 
perfused fibrin cardiac patch. 
Figure 42: Cardiac patch and fibrin vascular device setup. (a, b) fibrin vascular 
device made and perfused to remove gelatin (c) cardiac patch laid on top (d, 
e) diffusion from microfluidic channels to cardiac patch 
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Figure 43: Diffusion of calcein AM dye to rat neonatal ventricular monocytes within a fibrin composite patch. Yellow lines 
indicate channel boundaries and microthread outline after 75 minutes of perfusion. Image credit Megan Chrobak. 
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Chapter 8: Conclusions 
The goal of this project was to develop a novel method for the fabrication of a single layered, fibrin-
based vascular network that was able to reliably produce channels, had flow properties within 
physiological relevance, and had a diffusion rate that was capable of sustaining a live cell population on 
the surface. A detailed protocol was developed for the fabrication of fibrin vascular devices involving the 
development of sacrificial structures and a robust fibrin gel capable of maintaining channels. This goal 
had three main objectives. 
The first objective was the development of a novel technique for creating a consistently sized 
vascular network within a fibrin gel matrix. Success in this objective was defined as the ability to reliably 
produce and perfuse channels of consistent size without experiencing leakage. In this aim, these 
experiments were successful in creating sacrificial structures and fluidic channels that were not 
significantly different from each other, and reliably producing flow.  
The second objective of this project was determining the flow properties of liquids passing through 
the channels and the rate of diffusion through the gel, with success defined as collecting clear and 
accurate values for a variety of flow and diffusive properties and having said values fall within 
physiologically relevant ranges. In this objective, these experiments were very successful in obtaining 
favorable flow properties, but the diffusive properties did not match published literature, though likely 
due to the use of a robust fibrin gel. 
The final objective towards accomplishing the goal of this thesis was determining zones of cellular 
uptake on top of the device and observing differences in uptake zones between one and four hours of 
perfusion. Success was considered to be seeing and quantifying any change in uptake zones. In this 
objective, these experiments were also successful. 
 Overall, the morphological, diffusive, and flow properties of a monolayered fibrin vascular 
device showed strong correlation to physiological values, and several problems common with hydrogel 
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based fluidic systems were successfully addressed. These promising results, as well as preliminary future 
work studies directed at increasing complexity and decreasing the size of the vascular network, provide 
a strong argument for the continuation of development of this system, with the end goal of creating a 
functional microvascular network for an array of uses, including in vivo vascular repair, vascularization of 
full thickness tissue engineered constructs, and as an in vitro vascular model for drug testing. 
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Appendices: 
Appendix 1: SOLIDWORKS Drawing of Acrylic Mold 
 
104 
 
Appendix 2: Maximum Particle Speed Formula Integration 
 
Below is the integration of the average function value equation. The bonds were chosen in order to 
calculate the speed of the particles at the center of the channel based on knowing the average speed of 
particles tracked. Here, “a” is -h/2, “b” is h/2, “u” is speed, “h” is the width of the channel, and “y” is the 
distance from the center point.  
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Appendix 3: Particle Tracking Measurements 
 
Trial one: 
 
 
Trial 2:  
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Trial 3: 
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Appendix 4: Mean Diffusivity Measurements 
Appendix 4.1 40 kDa Dextran Diffusivity 
Diffusivity of 40 kDa Dextran (mm2/s) 
Distance from Channel Edge 0.1 mm 0.2 mm 0.3 mm 0.4 mm 0.5 mm 
0 Seconds 0.000E+00 0.000E+00 0.000E+00 0.000E+00 0.000E+00 
30 Seconds 4.107E-05 1.376E-04 2.655E-04 4.644E-04 7.201E-04 
60 Seconds 2.261E-05 7.170E-05 1.524E-04 2.027E-04 3.426E-04 
90 Seconds 1.832E-05 4.734E-05 9.321E-05 1.592E-04 2.400E-04 
120 Seconds 1.642E-05 3.787E-05 7.433E-05 1.118E-04 1.597E-04 
150 Seconds 1.446E-05 3.177E-05 6.297E-05 1.013E-04 1.558E-04 
180 Seconds 1.278E-05 3.179E-05 5.199E-05 8.666E-05 1.311E-04 
210 Seconds 1.196E-05 2.817E-05 4.831E-05 7.345E-05 1.200E-04 
240 Seconds 1.154E-05 2.701E-05 4.384E-05 5.902E-05 1.020E-04 
270 Seconds 1.087E-05 2.485E-05 4.315E-05 5.696E-05 8.745E-05 
300 Seconds 9.560E-06 2.332E-05 3.576E-05 4.841E-05 7.771E-05 
330 Seconds 9.648E-06 2.241E-05 3.617E-05 4.730E-05 7.512E-05 
360 Seconds 9.149E-06 2.106E-05 3.391E-05 5.020E-05 6.985E-05 
390 Seconds 9.190E-06 2.088E-05 3.306E-05 4.515E-05 6.209E-05 
420 Seconds 8.601E-06 1.983E-05 3.035E-05 4.367E-05 5.548E-05 
450 Seconds 8.557E-06 1.812E-05 2.954E-05 4.266E-05 5.984E-05 
480 Seconds 7.927E-06 1.881E-05 2.928E-05 4.033E-05 5.563E-05 
510 Seconds 8.039E-06 1.849E-05 2.862E-05 3.893E-05 4.654E-05 
540 Seconds 8.028E-06 1.742E-05 2.768E-05 3.779E-05 4.847E-05 
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570 Seconds 7.738E-06 1.728E-05 2.882E-05 3.678E-05 4.612E-05 
600 Seconds 7.867E-06 1.753E-05 2.753E-05 3.665E-05 4.494E-05 
630 Seconds 7.757E-06 1.682E-05 2.562E-05 3.507E-05 4.812E-05 
660 Seconds 7.665E-06 1.731E-05 2.592E-05 3.417E-05 4.302E-05 
690 Seconds 7.939E-06 1.674E-05 2.559E-05 3.296E-05 4.171E-05 
720 Seconds 7.738E-06 1.666E-05 2.573E-05 3.237E-05 4.136E-05 
750 Seconds 7.825E-06 1.643E-05 2.492E-05 3.327E-05 4.093E-05 
780 Seconds 7.859E-06 1.645E-05 2.426E-05 3.192E-05 3.949E-05 
810 Seconds 7.695E-06 1.643E-05 2.578E-05 3.161E-05 3.981E-05 
840 Seconds 8.114E-06 1.608E-05 2.509E-05 3.229E-05 4.135E-05 
870 Seconds 7.494E-06 1.604E-05 2.569E-05 3.046E-05 3.892E-05 
900 Seconds 5.618E-06 1.290E-05 2.202E-05 3.071E-05 3.794E-05 
930 Seconds 5.789E-06 1.304E-05 2.122E-05 2.937E-05 3.537E-05 
960 Seconds 5.657E-06 1.335E-05 2.278E-05 2.745E-05 3.576E-05 
990 Seconds 3.000E-06 7.762E-06 1.252E-05 1.799E-05 2.492E-05 
1020 Seconds 3.019E-06 7.421E-06 1.230E-05 1.830E-05 2.549E-05 
1050 Seconds 3.172E-06 7.226E-06 1.223E-05 1.786E-05 2.204E-05 
      
Mean 1.002E-05 2.468E-05 4.309E-05 6.340E-05 9.305E-05 
SD 6.733E-06 2.300E-05 4.669E-05 7.990E-05 1.272E-04 
System Mean 4.685E-05 
    
System SD 3.267E-05 
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Appendix 4.2: 250 kDa Dextran Diffusivity 
Diffusivity of 250 kDa Dextran (mm2/s) 
Distance from Channel Edge 0.1 mm 0.2 mm 0.3 mm 0.4 mm 0.5 mm 
0 Seconds 0.000E+00 0.000E+00 0.000E+00 0.000E+00 0.000E+00 
30 Seconds 3.021E-05 1.118E-04 2.853E-04 4.647E-04 6.760E-04 
60 Seconds 1.732E-05 6.051E-05 1.274E-04 2.162E-04 2.935E-04 
90 Seconds 1.198E-05 4.737E-05 8.221E-05 1.379E-04 2.040E-04 
120 Seconds 1.025E-05 2.994E-05 6.371E-05 1.074E-04 1.839E-04 
150 Seconds 8.655E-06 2.556E-05 5.653E-05 9.503E-05 1.405E-04 
180 Seconds 7.278E-06 2.218E-05 4.540E-05 7.195E-05 1.289E-04 
210 Seconds 6.372E-06 2.061E-05 4.207E-05 6.735E-05 1.082E-04 
240 Seconds 5.884E-06 1.698E-05 3.843E-05 6.041E-05 1.006E-04 
270 Seconds 5.479E-06 1.502E-05 3.437E-05 5.210E-05 7.855E-05 
300 Seconds 5.386E-06 1.523E-05 3.172E-05 4.796E-05 7.122E-05 
330 Seconds 4.968E-06 1.414E-05 2.841E-05 4.861E-05 6.396E-05 
360 Seconds 4.659E-06 1.313E-05 2.851E-05 3.758E-05 6.974E-05 
390 Seconds 4.467E-06 1.312E-05 2.595E-05 4.091E-05 6.377E-05 
420 Seconds 4.399E-06 1.209E-05 2.481E-05 3.835E-05 5.467E-05 
450 Seconds 4.166E-06 1.163E-05 2.466E-05 3.647E-05 5.012E-05 
480 Seconds 4.097E-06 1.143E-05 2.275E-05 3.366E-05 4.832E-05 
510 Seconds 4.049E-06 1.139E-05 2.119E-05 3.286E-05 4.810E-05 
540 Seconds 4.034E-06 1.065E-05 2.089E-05 3.178E-05 4.737E-05 
570 Seconds 4.045E-06 1.059E-05 2.157E-05 2.945E-05 4.361E-05 
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600 Seconds 3.884E-06 1.004E-05 1.836E-05 2.926E-05 4.195E-05 
630 Seconds 3.748E-06 9.913E-06 1.814E-05 2.875E-05 3.994E-05 
660 Seconds 3.708E-06 1.006E-05 1.811E-05 2.814E-05 4.094E-05 
690 Seconds 3.667E-06 9.632E-06 1.731E-05 2.634E-05 3.609E-05 
720 Seconds 3.545E-06 9.480E-06 1.695E-05 2.680E-05 3.486E-05 
750 Seconds 3.591E-06 9.497E-06 1.727E-05 2.669E-05 3.593E-05 
780 Seconds 3.611E-06 9.457E-06 1.646E-05 2.436E-05 3.454E-05 
810 Seconds 3.530E-06 9.011E-06 1.683E-05 2.374E-05 3.258E-05 
840 Seconds 3.718E-06 9.050E-06 1.579E-05 2.265E-05 3.234E-05 
870 Seconds 3.610E-06 8.865E-06 1.543E-05 2.418E-05 3.146E-05 
900 Seconds 4.399E-06 8.866E-06 1.562E-05 2.082E-05 3.127E-05 
930 Seconds 4.361E-06 8.816E-06 1.546E-05 2.133E-05 3.072E-05 
960 Seconds 4.186E-06 8.835E-06 1.515E-05 2.057E-05 2.930E-05 
990 Seconds 4.675E-06 7.695E-06 1.317E-05 2.126E-05 3.033E-05 
1020 Seconds 1.989E-06 6.104E-06 1.083E-05 1.677E-05 2.558E-05 
1050 Seconds 1.938E-06 6.268E-06 1.117E-05 1.692E-05 2.495E-05 
      
Mean 5.718E-06 1.708E-05 3.550E-05 5.637E-05 8.355E-05 
SD 5.168E-06 1.979E-05 4.876E-05 8.067E-05 1.174E-04 
System Mean 3.964E-05 
    
System SD 4.558E-05 
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Appendix 5: Shrinky-Dink Analysis 
 
Shapes tested for these experiments were concentric squares, with the “big” dimension referring to the 
outer shape, and the “small” dimension referring to the cut-out window. 
 
Normal Shrinky-Dinks 
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Ultra-Thick Shrinky-Dinks
 
 
